| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 7.37e-05 | 11 | 156 | 3 | GO:0052629 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 1.60e-04 | 14 | 156 | 3 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 1.99e-04 | 15 | 156 | 3 | GO:0052744 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.15e-04 | 38 | 156 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.43e-04 | 16 | 156 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.62e-04 | 230 | 156 | 8 | GO:0005516 | |
| GeneOntologyBiologicalProcess | cell division | MYH10 ANK3 CENPF APC THOC2 BIRC6 CEP164 CCNT1 SETDB2 SYCP2 CSNK1A1L BABAM1 FBXO5 BRCA2 CSNK1A1 SYCP1 PDS5A CDC25C | 5.25e-06 | 697 | 155 | 18 | GO:0051301 |
| GeneOntologyBiologicalProcess | DNA damage response | PMS1 MYO6 RBBP6 ATAD5 APC HUWE1 REV3L CEP164 TLK1 BABAM1 FBXO5 BRCA2 KMT5B ABRAXAS1 SYCP1 MARF1 PDS5A POLQ NFAT5 PCNA RAD17 | 1.05e-05 | 959 | 155 | 21 | GO:0006974 |
| GeneOntologyBiologicalProcess | chromatin organization | MYBBP1A CHD9 LMNB2 SAMD7 HUWE1 JMJD1C SETDB2 TLK1 RESF1 BABAM1 BRD2 BRCA2 KMT5B ABRAXAS1 TET1 SYCP1 RERE NFAT5 RAD17 | 4.45e-05 | 896 | 155 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 6.05e-05 | 131 | 155 | 7 | GO:1902749 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MYBBP1A CENPF CHD9 LMNB2 SAMD7 HUWE1 JMJD1C SETDB2 TLK1 RESF1 BABAM1 BRD2 BRCA2 KMT5B ABRAXAS1 TET1 SYCP1 RERE NFAT5 RAD17 | 6.16e-05 | 999 | 155 | 20 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PMS1 IPO5 NOLC1 NRIP1 CWF19L2 MYBBP1A RGPD1 POU2F1 ICE1 SAMD7 THOC2 JMJD1C BCLAF3 CCNT1 CSNK1A1L BABAM1 BRCA2 UBAP2L CSNK1A1 ABRAXAS1 WBP4 TET1 SAGE1 RERE MGA NUP153 PCNA | 4.00e-06 | 1377 | 157 | 27 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | NOLC1 ZC3H14 NRIP1 BMP2K RBBP6 ZMYM2 ICE1 THOC2 CSNK1A1L BABAM1 BRD2 CSNK1A1 ABRAXAS1 WBP4 YLPM1 NHS SAGE1 RERE PCNA SH3BP5 SP140 | 4.21e-06 | 903 | 157 | 21 | GO:0016604 |
| GeneOntologyCellularComponent | chromosomal region | CENPF APC THOC2 SYCP2 CSNK1A1L BRCA2 KMT5B CSNK1A1 SYCP1 PDS5A PCNA RAD17 | 8.37e-05 | 421 | 157 | 12 | GO:0098687 |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 1.12e-04 | 13 | 157 | 3 | GO:0030877 | |
| GeneOntologyCellularComponent | myosin II filament | 1.67e-04 | 3 | 157 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | lateral element | 3.69e-04 | 19 | 157 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | myosin filament | 8.47e-04 | 25 | 157 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin complex | 1.01e-03 | 59 | 157 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.07e-03 | 210 | 157 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | axon | ADCY10 ZC3H14 MYH10 ANK3 MYCBP2 MYO6 APC ADGRL1 ATAT1 SYNJ1 SYNJ2 MYH14 SCN10A UNC13C DMD FKBP4 | 1.12e-03 | 891 | 157 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.17e-03 | 276 | 157 | 8 | GO:0000775 | |
| GeneOntologyCellularComponent | myosin II complex | 1.19e-03 | 28 | 157 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.32e-03 | 349 | 157 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.34e-03 | 108 | 157 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | cell leading edge | 1.43e-03 | 500 | 157 | 11 | GO:0031252 | |
| GeneOntologyCellularComponent | BRCA1-A complex | 1.52e-03 | 8 | 157 | 2 | GO:0070531 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.58e-03 | 112 | 157 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.59e-03 | 431 | 157 | 10 | GO:0031253 | |
| GeneOntologyCellularComponent | nuclear speck | ZC3H14 NRIP1 BMP2K RBBP6 THOC2 CSNK1A1L BRD2 CSNK1A1 WBP4 YLPM1 | 1.59e-03 | 431 | 157 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | condensed chromosome | 2.29e-03 | 307 | 157 | 8 | GO:0000793 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 2.42e-03 | 10 | 157 | 2 | GO:0097539 | |
| Domain | DUF1866 | 6.84e-05 | 2 | 155 | 2 | IPR015047 | |
| Domain | DUF1866 | 6.84e-05 | 2 | 155 | 2 | PF08952 | |
| Domain | DUF1866 | 6.84e-05 | 2 | 155 | 2 | SM01165 | |
| Domain | SYCP1/2 | 2.04e-04 | 3 | 155 | 2 | IPR024835 | |
| Domain | Myosin_N | 2.37e-04 | 15 | 155 | 3 | PF02736 | |
| Domain | Myosin_N | 2.37e-04 | 15 | 155 | 3 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 2.70e-04 | 38 | 155 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.70e-04 | 38 | 155 | 4 | PS51456 | |
| Domain | Myosin_head | 2.70e-04 | 38 | 155 | 4 | PF00063 | |
| Domain | MYSc | 2.70e-04 | 38 | 155 | 4 | SM00242 | |
| Domain | IQ | 3.09e-04 | 71 | 155 | 5 | PF00612 | |
| Domain | Myosin_tail_1 | 4.17e-04 | 18 | 155 | 3 | PF01576 | |
| Domain | Myosin_tail | 4.17e-04 | 18 | 155 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.93e-04 | 19 | 155 | 3 | IPR027401 | |
| Domain | - | 4.93e-04 | 19 | 155 | 3 | 4.10.270.10 | |
| Domain | WW | 6.68e-04 | 48 | 155 | 4 | SM00456 | |
| Domain | Syja_N | 6.73e-04 | 5 | 155 | 2 | PF02383 | |
| Domain | Myosin_S1_N | 6.73e-04 | 5 | 155 | 2 | IPR008989 | |
| Domain | SAC | 6.73e-04 | 5 | 155 | 2 | PS50275 | |
| Domain | SAC_dom | 6.73e-04 | 5 | 155 | 2 | IPR002013 | |
| Domain | WW_DOMAIN_1 | 8.42e-04 | 51 | 155 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 8.42e-04 | 51 | 155 | 4 | PS50020 | |
| Domain | WW_dom | 9.06e-04 | 52 | 155 | 4 | IPR001202 | |
| Domain | IQ_motif_EF-hand-BS | 9.20e-04 | 90 | 155 | 5 | IPR000048 | |
| Domain | IQ | 1.07e-03 | 93 | 155 | 5 | PS50096 | |
| Domain | - | 1.73e-03 | 207 | 155 | 7 | 1.25.40.10 | |
| Domain | UBA | 1.93e-03 | 30 | 155 | 3 | SM00165 | |
| Domain | IPPc | 2.95e-03 | 10 | 155 | 2 | IPR000300 | |
| Domain | IPPc | 2.95e-03 | 10 | 155 | 2 | SM00128 | |
| Domain | UBA | 3.27e-03 | 36 | 155 | 3 | PF00627 | |
| Domain | TPR-like_helical_dom | 3.36e-03 | 233 | 155 | 7 | IPR011990 | |
| Domain | Ribosomal_L7Ae | 3.58e-03 | 11 | 155 | 2 | PF01248 | |
| Domain | Ribosomal_L7Ae/L30e/S12e/Gad45 | 4.28e-03 | 12 | 155 | 2 | IPR004038 | |
| Domain | IQ | 4.63e-03 | 81 | 155 | 4 | SM00015 | |
| Domain | UBA | 5.79e-03 | 44 | 155 | 3 | IPR015940 | |
| Domain | EF-hand_like | 6.69e-03 | 15 | 155 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 6.69e-03 | 15 | 155 | 2 | PF00387 | |
| Domain | - | 6.69e-03 | 15 | 155 | 2 | 3.30.1330.30 | |
| Domain | PLCYc | 6.69e-03 | 15 | 155 | 2 | SM00149 | |
| Domain | L30e-like | 6.69e-03 | 15 | 155 | 2 | IPR029064 | |
| Domain | PLipase_C_Pinositol-sp_Y | 6.69e-03 | 15 | 155 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 6.69e-03 | 15 | 155 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 6.69e-03 | 15 | 155 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 6.69e-03 | 15 | 155 | 2 | IPR015359 | |
| Domain | TPR_1 | 6.71e-03 | 90 | 155 | 4 | IPR001440 | |
| Domain | TPR_1 | 6.71e-03 | 90 | 155 | 4 | PF00515 | |
| Domain | WW | 6.96e-03 | 47 | 155 | 3 | PF00397 | |
| Domain | UBA | 6.96e-03 | 47 | 155 | 3 | PS50030 | |
| Pubmed | NRIP1 MYCBP2 CENPF RGPD1 APC ZMYM2 ICE1 HUWE1 BIRC6 JMJD1C GTF3C3 RESF1 ZFHX4 BRCA2 SYNJ1 ZNF592 RAB3GAP2 TET1 ARID5B RERE MGA AKAP1 OBI1 | 2.62e-18 | 418 | 159 | 23 | 34709266 | |
| Pubmed | IPO5 NOLC1 ZC3H14 MYBBP1A MYH10 SERBP1 MYCBP2 CENPF LMNB2 HUWE1 THOC2 BIRC6 GTF3C3 MYH14 UBAP2L PRRC2C DDX18 YLPM1 MACF1 PDS5A FKBP4 NUP153 | 3.49e-13 | 653 | 159 | 22 | 22586326 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | IPO5 NOLC1 MYBBP1A SERBP1 CENPF CNOT10 RGPD1 APC ZMYM2 HMMR GTF3C3 BCLAF3 DECR1 TLK1 CSNK1A1L FBXO5 PIGR SYNJ2 CSNK1A1 YLPM1 SYCP1 PDS5A POC5 HSF2 CDC25C OBI1 NUP153 PCNA | 5.08e-13 | 1155 | 159 | 28 | 20360068 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 NOLC1 ZC3H14 CWF19L2 MYBBP1A SERBP1 RBBP6 ATAD5 FNBP4 ZMYM2 ICE1 THOC2 JMJD1C CCNT1 BRD2 BRCA2 UBAP2L PRRC2C DDX18 WBP4 YLPM1 MARF1 PDS5A MGA NUP153 | 1.94e-12 | 954 | 159 | 25 | 36373674 |
| Pubmed | NOLC1 ARHGAP32 MYBBP1A MYH10 MYO6 RBBP6 ATAD5 CNOT10 RGPD1 ZMYM2 POU2F1 TNRC6C JMJD1C GTF3C3 RESF1 BRD2 ZFHX4 ZNF592 MYH14 UBAP2L PRRC2C DDX18 YLPM1 ARID5B MARF1 PDS5A RERE MGA FKBP4 PCNA | 2.56e-12 | 1429 | 159 | 30 | 35140242 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 MYH10 ANK3 MYCBP2 MYO6 VEZT VPS13C RALGAPB FNBP4 ADGRL1 CHD9 TNRC6C HUWE1 PDE10A ATAT1 ADCY3 JMJD1C NPLOC4 TLK1 BCAP29 SYNJ2 MYH14 UBAP2L CSNK1A1 LPCAT3 ARID5B MACF1 RERE NFAT5 WNK2 | 7.13e-12 | 1489 | 159 | 30 | 28611215 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PMS1 NOLC1 ZC3H14 MYBBP1A MYH10 SERBP1 MYO6 RBBP6 ATAD5 ZMYM2 FAM114A2 ICE1 THOC2 NPLOC4 CCNT1 SYNJ1 UBAP2L PRRC2C YLPM1 MACF1 AKAP1 FKBP4 NUP153 PCNA | 8.45e-12 | 934 | 159 | 24 | 33916271 |
| Pubmed | CWF19L2 ZMYM2 CHD9 REV3L CCNT1 RESF1 BRD2 BRCA2 CSNK1A1 DDX18 PDS5A POLQ MGA | 3.64e-11 | 222 | 159 | 13 | 37071664 | |
| Pubmed | ZC3H14 MYBBP1A SERBP1 ANK3 MYCBP2 RBBP6 FNBP4 HUWE1 THOC2 JMJD1C GTF3C3 SYNJ1 UBAP2L PRRC2C RAB3GAP2 TET1 YLPM1 MGA | 8.73e-11 | 549 | 159 | 18 | 38280479 | |
| Pubmed | ARHGAP32 MYH10 MYH11 ANK3 MYO6 RBBP6 APC ZMYM2 ADGRL1 TLK1 SYNJ2 MACF1 DMD MGA OBI1 WNK2 NUP153 | 1.11e-10 | 486 | 159 | 17 | 20936779 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | PMS1 CWF19L2 MYO6 ZMYM2 HMMR JMJD1C CCNT1 TLK1 RESF1 BRCA2 PIGR MYH14 UBAP2L PDS5A MGA PCNA | 2.63e-10 | 444 | 159 | 16 | 34795231 |
| Pubmed | IPO5 NOLC1 ZC3H14 MYBBP1A SERBP1 RBBP6 ATAD5 THUMPD1 CHD9 LMNB2 THOC2 NPLOC4 GTF3C3 CCNT1 BRD2 ZNF592 CSNK1A1 DDX18 YLPM1 PDS5A FKBP4 NUP153 PCNA | 2.77e-10 | 1014 | 159 | 23 | 32416067 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 ZC3H14 MYBBP1A SERBP1 MYCBP2 CENPF RBBP6 ATAD5 HMMR THOC2 BIRC6 GTF3C3 DECR1 UBAP2L PRRC2C DDX18 MACF1 HSF2 AKAP1 PCNA | 3.46e-10 | 759 | 159 | 20 | 35915203 |
| Pubmed | ARHGAP32 MYBBP1A MYH10 ANK3 MYCBP2 CENPF RGPD1 APC ZMYM2 LMNB2 HUWE1 CSNK1A1L SYNJ1 UBAP2L CSNK1A1 PRRC2C YLPM1 MACF1 MGA WNK2 NUP153 SH3BP5 | 6.15e-10 | 963 | 159 | 22 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZC3H14 SERBP1 BMP2K MYCBP2 MYO6 ATAD5 CNOT10 APC HMMR SYNJ2 MYH14 UBAP2L PRRC2C DDX18 YLPM1 MARF1 SECISBP2 MACF1 MGA | 1.05e-09 | 724 | 159 | 19 | 36232890 |
| Pubmed | MYCBP2 VEZT VPS13C APC ICE1 LMNB2 HUWE1 BIRC6 JMJD1C FBXO5 SYNJ2 CCDC47 RAB3GAP2 WBP4 YLPM1 SECISBP2 POC5 MGA AKAP1 | 1.29e-09 | 733 | 159 | 19 | 34672954 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 ANK3 MYCBP2 RBBP6 ICE1 JMJD1C SYCP2 SERPINI2 ZFHX4 ZNF592 PRRC2C MACF1 OBI1 NUP153 | 1.42e-09 | 361 | 159 | 14 | 26167880 |
| Pubmed | NOLC1 MYBBP1A SERBP1 CENPF RBBP6 APC ZMYM2 HUWE1 THOC2 UBAP2L NHS CDC25C OBI1 FKBP4 NUP153 SH3BP5 | 1.59e-09 | 503 | 159 | 16 | 16964243 | |
| Pubmed | NOLC1 MYBBP1A MYH10 MYH11 CENPF RGPD1 FAM114A2 LMNB2 PDE10A CEP128 FER1L6 TLK1 BRD2 KIAA0825 MYH14 CCDC47 PRRC2C YLPM1 SYCP1 MARF1 MACF1 DMD SPAG17 POLQ ATP2B2 OBI1 | 2.24e-09 | 1442 | 159 | 26 | 35575683 | |
| Pubmed | PMS1 ARHGAP32 MYBBP1A MYH10 ANK3 MYCBP2 VEZT ATAD5 RALGAPB MTMR1 HUWE1 BIRC6 BABAM1 BRD2 CCDC47 YLPM1 NHS POC5 DMD CDC25C FKBP4 NUP153 | 2.96e-09 | 1049 | 159 | 22 | 27880917 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | NOLC1 MYBBP1A MYH10 MYCBP2 MYO6 LMNB2 HUWE1 JMJD1C GTF3C3 MYH14 UBAP2L PRRC2C DDX18 ERP29 FKBP4 NUP153 PCNA | 4.86e-09 | 624 | 159 | 17 | 33729478 |
| Pubmed | IPO5 ARHGAP32 MYBBP1A SERBP1 ANK3 MYO6 APC MTMR1 JMJD1C NPLOC4 FBXO5 UBAP2L CCDC47 PRRC2C RAB3GAP2 MACF1 PDS5A NUP153 | 4.89e-09 | 708 | 159 | 18 | 39231216 | |
| Pubmed | IPO5 NOLC1 ZC3H14 MYBBP1A RBBP6 HUWE1 BIRC6 GTF3C3 BRD2 ZNF592 UBAP2L PRRC2C WBP4 PDS5A PCNA | 4.90e-09 | 469 | 159 | 15 | 27634302 | |
| Pubmed | MYBBP1A MYH10 SERBP1 MYCBP2 APC THUMPD1 CHD9 THOC2 GTF3C3 DECR1 CCNT1 ZNF592 UBAP2L CSNK1A1 DDX18 YLPM1 DMD NFAT5 NUP153 | 6.41e-09 | 809 | 159 | 19 | 32129710 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 6.88e-09 | 87 | 159 | 8 | 17148452 | |
| Pubmed | IPO5 NOLC1 ZC3H14 MYBBP1A MYH10 SERBP1 MYO6 RBBP6 APC CHD9 HMMR HUWE1 THOC2 ZC3H6 CCNT1 MYH14 CSNK1A1 DDX18 NHS MGA NFAT5 FKBP4 PCNA | 1.38e-08 | 1247 | 159 | 23 | 27684187 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 CWF19L2 RBBP6 APC ZMYM2 HUWE1 RESF1 BABAM1 BRCA2 SYNJ1 PRRC2C ARID5B SECISBP2 MACF1 HSF2 OBI1 | 1.43e-08 | 588 | 159 | 16 | 38580884 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 MYH10 SERBP1 BMP2K VPS13C RGPD1 APC TNRC6C CEP128 CEP164 DECR1 BRCA2 SYNJ1 SYNJ2 CSNK1A1 POC5 MGA FKBP4 PCNA | 1.49e-08 | 853 | 159 | 19 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 ARHGAP32 CDR2 MYCBP2 RALGAPB APC ATAT1 RESF1 SYNJ1 SYNJ2 CSNK1A1 PRRC2C RAB3GAP2 TET1 NHS MACF1 CDC25C AKAP1 OBI1 | 1.73e-08 | 861 | 159 | 19 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 MYBBP1A MYCBP2 RBBP6 RALGAPB FNBP4 ZMYM2 POU2F1 HUWE1 THOC2 TLK1 BRD2 ZNF592 UBAP2L YLPM1 RERE AKAP1 NUP153 | 1.92e-08 | 774 | 159 | 18 | 15302935 |
| Pubmed | MYBBP1A MYH10 MYH11 MYCBP2 FNBP4 THOC2 MYH14 PRRC2C YLPM1 ATP2B2 | 3.52e-08 | 202 | 159 | 10 | 24639526 | |
| Pubmed | IPO5 ARHGAP32 PDE1C MYBBP1A MYH10 MYH11 SERBP1 ANK3 OXR1 MYO6 APC MTMR1 ADGRL1 BCAS1 CSNK1A1L SYNJ1 MYH14 UBAP2L CSNK1A1 PRRC2C MACF1 DMD ATP2B2 WNK2 | 3.92e-08 | 1431 | 159 | 24 | 37142655 | |
| Pubmed | PMS1 IPO5 MYBBP1A MYH10 ANK3 BMP2K MYO6 BABAM1 BRCA2 PIGR ABRAXAS1 CRNN MACF1 PDS5A FKBP4 NUP153 | 4.06e-08 | 634 | 159 | 16 | 34591612 | |
| Pubmed | NOLC1 VEZT RBBP6 ATAD5 CHD9 REV3L CCNT1 SETDB2 RESF1 BRD2 FBXO5 ZFHX4 KMT5B ZNF592 DDX18 CRNN LRP4 MACF1 RERE MGA SP140 | 4.47e-08 | 1116 | 159 | 21 | 31753913 | |
| Pubmed | 6.13e-08 | 76 | 159 | 7 | 27542412 | ||
| Pubmed | IPO5 NOLC1 MYBBP1A MYH10 CENPF CHD9 HMMR TNRC6C MYH14 UBAP2L PDS5A FKBP4 NUP153 PCNA | 7.29e-08 | 494 | 159 | 14 | 26831064 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO5 NOLC1 MYBBP1A MYH10 BMP2K MYCBP2 MYO6 CENPF VEZT VPS13C THUMPD1 LMNB2 TNRC6C HUWE1 BIRC6 DECR1 BABAM1 CCDC47 RAB3GAP2 DDX18 SECISBP2 RERE AKAP1 FKBP4 | 8.94e-08 | 1496 | 159 | 24 | 32877691 |
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 9.38e-08 | 3 | 159 | 3 | 25242043 | |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 28655862 | ||
| Pubmed | IPO5 MYBBP1A SERBP1 MYCBP2 MYO6 CNOT10 PANX1 HMMR HUWE1 BIRC6 ADCY3 BCAP29 MYH14 CCDC47 CSNK1A1 PRRC2C LPCAT3 DDX18 MARF1 ERP29 AKAP1 | 9.60e-08 | 1168 | 159 | 21 | 19946888 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 CWF19L2 MYBBP1A MYH10 MYCBP2 RBBP6 FNBP4 APC ZMYM2 MTMR1 CHD9 LMNB2 THOC2 ZC3H6 GTF3C3 BRD2 DDX18 YLPM1 MACF1 PDS5A | 1.28e-07 | 1082 | 159 | 20 | 38697112 |
| Pubmed | NOLC1 MYBBP1A ANK3 BMP2K APC HUWE1 THOC2 ADCY3 RESF1 SYNJ1 UBAP2L TET1 ARID5B MACF1 ERP29 BIN2 MGA NFAT5 NUP153 RAD17 | 1.32e-07 | 1084 | 159 | 20 | 11544199 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 IPO5 ATAD5 ZMYM2 POU2F1 CHD9 JMJD1C GTF3C3 CCNT1 SETDB2 BRD2 ZNF592 ABRAXAS1 PDS5A MGA | 1.47e-07 | 608 | 159 | 15 | 36089195 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 ZC3H14 MYBBP1A MYH10 CENPF ZMYM2 LMNB2 HUWE1 THOC2 JMJD1C GTF3C3 BRD2 ZNF592 DDX18 YLPM1 ERP29 FKBP4 NUP153 PCNA | 1.50e-07 | 989 | 159 | 19 | 36424410 |
| Pubmed | 1.62e-07 | 130 | 159 | 8 | 12421765 | ||
| Pubmed | NOLC1 ZC3H14 MYCBP2 ZMYM2 POU2F1 CHD9 HMMR THOC2 JMJD1C CCNT1 TLK1 RESF1 CSNK1A1 PRRC2C RAB3GAP2 PDS5A ERP29 BIN2 FKBP4 NUP153 | 1.74e-07 | 1103 | 159 | 20 | 34189442 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 MYBBP1A ATAD5 CNOT10 CHD9 THOC2 GTF3C3 CCNT1 BRD2 KMT5B ZNF592 DDX18 MGA OBI1 | 1.84e-07 | 533 | 159 | 14 | 30554943 |
| Pubmed | 2.49e-07 | 57 | 159 | 6 | 21555454 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 NOLC1 ZC3H14 MYBBP1A MYCBP2 CENPF LMNB2 HUWE1 THOC2 BRD2 MYH14 UBAP2L DDX18 YLPM1 MACF1 MGA FKBP4 NUP153 PCNA | 2.56e-07 | 1024 | 159 | 19 | 24711643 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | IPO5 MYBBP1A MYH10 ATAD5 ZMYM2 CHD9 GTF3C3 BRD2 DDX18 PDS5A NUP153 PCNA | 3.02e-07 | 394 | 159 | 12 | 27248496 |
| Pubmed | SECISBP2L MYBBP1A MYH10 MYH11 SERBP1 MYO6 FNBP4 HMMR THOC2 NPLOC4 GTF3C3 DECR1 ANKRD36B MYH14 UBAP2L CCDC47 PRRC2C DDX18 YLPM1 MARF1 ERP29 PCNA | 3.25e-07 | 1371 | 159 | 22 | 36244648 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IPO5 MYBBP1A MYH10 SERBP1 ANK3 MYCBP2 MYO6 MTMR1 HUWE1 GTF3C3 UBAP2L PRRC2C RAB3GAP2 MACF1 PDS5A ERP29 OBI1 FKBP4 NUP153 PCNA | 3.32e-07 | 1149 | 159 | 20 | 35446349 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.42e-07 | 197 | 159 | 9 | 20811636 | |
| Pubmed | The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. | 3.74e-07 | 4 | 159 | 3 | 32728212 | |
| Pubmed | FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning. | 3.74e-07 | 4 | 159 | 3 | 31338967 | |
| Pubmed | SERBP1 VEZT VPS13C FAM114A2 LMNB2 NPLOC4 BABAM1 BCAP29 UBAP2L CCDC47 PRRC2C RAB3GAP2 AKAP1 NUP153 | 3.95e-07 | 568 | 159 | 14 | 37774976 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.95e-07 | 146 | 159 | 8 | 23892456 | |
| Pubmed | ARHGAP32 ANK3 MYO6 APC JMJD1C CSNK1A1 SECISBP2 NHS MACF1 NUP153 | 4.09e-07 | 263 | 159 | 10 | 34702444 | |
| Pubmed | 4.10e-07 | 100 | 159 | 7 | 10048485 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.22e-07 | 202 | 159 | 9 | 33005030 | |
| Pubmed | MYH10 RALGAPB ADGRL1 TNRC6C ADCY3 UBAP2L PRRC2C RAB3GAP2 MACF1 RERE NFAT5 PLCE1 | 4.26e-07 | 407 | 159 | 12 | 12693553 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NOLC1 MYBBP1A MYH10 SERBP1 MYCBP2 MYO6 CNOT10 BCAS1 JMJD1C GTF3C3 TLK1 BABAM1 PIGR CCDC82 KMT5B CCDC47 RAB3GAP2 PDS5A POLQ OBI1 FKBP4 | 4.54e-07 | 1284 | 159 | 21 | 17353931 |
| Pubmed | IPO5 NRIP1 ANK3 OXR1 MYCBP2 MYO6 APC ZMYM2 CHD9 HUWE1 REV3L BRD2 SYNJ1 ZNF592 MYH14 DDX18 YLPM1 ARID5B LRP4 MACF1 SH3BP5 | 4.60e-07 | 1285 | 159 | 21 | 35914814 | |
| Pubmed | IPO5 NRIP1 MYCBP2 SGCB BIRC6 JMJD1C XIRP2 ZNF592 MYH14 MACF1 MGA AKAP1 PLCE1 | 5.38e-07 | 497 | 159 | 13 | 23414517 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 NOLC1 MYBBP1A MYH10 SERBP1 MYO6 CENPF VPS13C LMNB2 HUWE1 THOC2 GTF3C3 MYH14 UBAP2L CCDC47 RAB3GAP2 DDX18 PDS5A ERP29 FKBP4 NUP153 PCNA | 6.20e-07 | 1425 | 159 | 22 | 30948266 |
| Pubmed | MYH10 ANK3 MYCBP2 MYO6 RBBP6 FNBP4 ZMYM2 HUWE1 ZNF592 YLPM1 SECISBP2 MACF1 PLCG2 MGA | 6.33e-07 | 591 | 159 | 14 | 15231748 | |
| Pubmed | NOLC1 MYH10 SERBP1 MYO6 CENPF RBBP6 FNBP4 CCNT1 TLK1 SYNJ1 YLPM1 NUP153 PCNA | 6.57e-07 | 506 | 159 | 13 | 30890647 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | ZC3H14 MYH10 MYCBP2 MYO6 RBBP6 CNOT10 ZMYM2 HUWE1 SYNJ1 YLPM1 MACF1 | 8.77e-07 | 358 | 159 | 11 | 32460013 |
| Pubmed | CKIα ablation highlights a critical role for p53 in invasiveness control. | 9.31e-07 | 5 | 159 | 3 | 21331045 | |
| Pubmed | A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. | 9.31e-07 | 5 | 159 | 3 | 23890787 | |
| Pubmed | 9.56e-07 | 17 | 159 | 4 | 24124579 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | IPO5 MYCBP2 ZMYM2 HUWE1 ZNF592 YLPM1 ARID5B RERE OBI1 NUP153 | 9.65e-07 | 289 | 159 | 10 | 23752268 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MYBBP1A MYCBP2 FNBP4 APC HUWE1 GTF3C3 ZNF592 MYH14 UBAP2L DDX18 YLPM1 NUP153 | 9.67e-07 | 440 | 159 | 12 | 34244565 |
| Pubmed | PMS1 NOLC1 MYBBP1A ANK3 MYCBP2 MYO6 VEZT ATAD5 RALGAPB FNBP4 MTMR1 LMNB2 HMMR GTF3C3 BRD2 CCDC47 RAB3GAP2 DDX18 MACF1 ERP29 AKAP1 FKBP4 | 1.25e-06 | 1487 | 159 | 22 | 33957083 | |
| Pubmed | NOLC1 ARHGAP32 MYH10 SERBP1 ANK3 MYCBP2 VEZT RGPD1 APC ADGRL1 HUWE1 BIRC6 DECR1 SYNJ1 UBAP2L PRRC2C RAB3GAP2 MACF1 WNK2 | 1.26e-06 | 1139 | 159 | 19 | 36417873 | |
| Pubmed | CENPF ATAD5 ICE1 THOC2 JMJD1C GTF3C3 TLK1 BABAM1 BRCA2 ABRAXAS1 SAGE1 MGA | 1.31e-06 | 453 | 159 | 12 | 29656893 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 1.86e-06 | 125 | 159 | 7 | 21654808 | |
| Pubmed | ZC3H14 MYBBP1A MYH10 SERBP1 RBBP6 FNBP4 THOC2 GTF3C3 DECR1 CCNT1 ZNF592 MYH14 DDX18 CRNN NFAT5 NUP153 | 1.91e-06 | 847 | 159 | 16 | 35850772 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 ZC3H14 MYBBP1A CENPF RBBP6 ATAD5 FNBP4 ZMYM2 LMNB2 THOC2 JMJD1C BABAM1 BRD2 ABRAXAS1 DDX18 YLPM1 ARID5B PDS5A MGA NUP153 | 2.07e-06 | 1294 | 159 | 20 | 30804502 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH10 NPAS3 ZMYM2 THUMPD1 MTMR1 POU2F1 LMNB2 HUWE1 REV3L JMJD1C GTF3C3 ZFHX4 PRRC2C PDS5A MGA OBI1 | 2.22e-06 | 857 | 159 | 16 | 25609649 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | IPO5 MYH10 SERBP1 RBBP6 RGPD1 HUWE1 JMJD1C CCNT1 BRD2 SYNJ2 UBAP2L PRRC2C DDX18 PCNA | 2.51e-06 | 665 | 159 | 14 | 30457570 |
| Pubmed | NOLC1 MYBBP1A ANK3 BMP2K MYO6 VPS13C APC HUWE1 BIRC6 GTF3C3 DDX18 PDS5A MGA AKAP1 PCNA | 3.13e-06 | 777 | 159 | 15 | 35844135 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | IPO5 MYBBP1A MYH10 CENPF CEP128 UBAP2L CSNK1A1 RAB3GAP2 DDX18 MACF1 OBI1 FKBP4 | 3.47e-06 | 498 | 159 | 12 | 36634849 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.62e-06 | 262 | 159 | 9 | 36880596 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 MYBBP1A MYH10 MYCBP2 MYO6 LMNB2 HUWE1 BIRC6 GTF3C3 DECR1 CCNT1 MYH14 CCDC47 DDX18 MACF1 PDS5A ERP29 PLCG2 MGA PCNA | 4.04e-06 | 1353 | 159 | 20 | 29467282 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 MYBBP1A MYH10 RBBP6 ZMYM2 JMJD1C CCNT1 YLPM1 PDS5A NUP153 | 4.22e-06 | 341 | 159 | 10 | 32971831 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | ZC3H14 CWF19L2 MYBBP1A SERBP1 RBBP6 RGPD1 FNBP4 DECR1 CSNK1A1L CCDC47 CSNK1A1 PRRC2C YLPM1 PLCG2 | 4.60e-06 | 701 | 159 | 14 | 30196744 |
| Pubmed | OXR1 MYCBP2 APC ADGRL1 BCAS1 SYNJ1 UBAP2L RAB3GAP2 MACF1 ATP2B2 | 4.92e-06 | 347 | 159 | 10 | 17114649 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | IPO5 MYBBP1A MYH10 MYH11 SERBP1 ANK3 MYCBP2 HUWE1 MYH14 CSNK1A1 DDX18 MACF1 ERP29 SPAG17 FKBP4 | 4.93e-06 | 807 | 159 | 15 | 30575818 |
| Pubmed | ZC3H14 SERBP1 BMP2K RBBP6 ATAD5 CNOT10 RALGAPB APC ZMYM2 ICE1 HMMR CEP164 CCNT1 BABAM1 BRD2 ZNF592 CCDC47 CSNK1A1 MACF1 PDS5A AKAP1 | 5.10e-06 | 1497 | 159 | 21 | 31527615 | |
| Pubmed | IPO5 ZC3H14 ARHGAP32 ZMYM2 LMNB2 HUWE1 CCNT1 UBAP2L CCDC47 PDS5A DMD MGA AKAP1 FKBP4 NUP153 PCNA | 5.15e-06 | 916 | 159 | 16 | 32203420 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 ZC3H14 MYBBP1A MYH10 SERBP1 MYO6 CENPF RBBP6 LMNB2 HMMR THOC2 GTF3C3 DECR1 CSNK1A1 PRRC2C DDX18 FKBP4 NUP153 PCNA | 5.23e-06 | 1257 | 159 | 19 | 36526897 |
| Pubmed | 5.95e-06 | 149 | 159 | 7 | 25184681 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.76e-06 | 283 | 159 | 9 | 30585729 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 7.30e-06 | 363 | 159 | 10 | 14691545 | |
| Pubmed | 7.72e-06 | 9 | 159 | 3 | 9601641 | ||
| Pubmed | 8.24e-06 | 103 | 159 | 6 | 32744500 | ||
| Pubmed | NRIP1 ARHGAP32 MYO6 ATAD5 RGPD1 ZMYM2 REV3L FER1L6 ANKRD36B CCDC47 WBP4 ARID5B CCDC102B | 8.24e-06 | 638 | 159 | 13 | 31182584 | |
| Pubmed | 9.93e-06 | 225 | 159 | 8 | 12168954 | ||
| Pubmed | NOLC1 MYBBP1A SERBP1 RBBP6 ATAD5 LMNB2 THOC2 BRCA2 PIGR MYH14 DDX18 PDS5A PCNA | 1.04e-05 | 652 | 159 | 13 | 31180492 | |
| Interaction | PHF21A interactions | MYCBP2 CENPF APC ZMYM2 ICE1 HUWE1 BIRC6 JMJD1C RESF1 ZFHX4 BRCA2 SYNJ1 ZNF592 TET1 ARID5B MGA AKAP1 OBI1 | 2.29e-10 | 343 | 158 | 18 | int:PHF21A |
| Interaction | RCOR1 interactions | MYH10 MYCBP2 CENPF APC ZMYM2 ICE1 HUWE1 BIRC6 JMJD1C RESF1 ZFHX4 BRCA2 SYNJ1 ZNF592 RAB3GAP2 TET1 ARID5B MGA AKAP1 OBI1 | 2.02e-09 | 494 | 158 | 20 | int:RCOR1 |
| Interaction | KDM1A interactions | NRIP1 MYCBP2 CENPF APC ZMYM2 ICE1 HUWE1 THOC2 BIRC6 JMJD1C GTF3C3 RESF1 ZFHX4 BRCA2 SYNJ1 ZNF592 CSNK1A1 RAB3GAP2 TET1 ARID5B PDS5A RERE MGA AKAP1 OBI1 FKBP4 | 2.03e-08 | 941 | 158 | 26 | int:KDM1A |
| Interaction | SMC5 interactions | PMS1 NOLC1 ZC3H14 CWF19L2 MYBBP1A SERBP1 RBBP6 ATAD5 FNBP4 ZMYM2 ICE1 REV3L THOC2 JMJD1C CCNT1 BRD2 BRCA2 UBAP2L PRRC2C DDX18 WBP4 YLPM1 MARF1 PDS5A MGA NUP153 | 6.85e-08 | 1000 | 158 | 26 | int:SMC5 |
| Interaction | KCNA3 interactions | ADCY10 IPO5 NRIP1 ARHGAP32 MYBBP1A SERBP1 ANK3 MYO6 RBBP6 APC MTMR1 CHD9 THOC2 JMJD1C NPLOC4 FBXO5 UBAP2L CCDC47 PRRC2C RAB3GAP2 MACF1 PDS5A POLQ NUP153 | 8.03e-08 | 871 | 158 | 24 | int:KCNA3 |
| Interaction | SIRT7 interactions | IPO5 NOLC1 ZC3H14 MYBBP1A MYH10 SERBP1 MYCBP2 CENPF LMNB2 HUWE1 THOC2 BIRC6 GTF3C3 MYH14 UBAP2L PRRC2C DDX18 YLPM1 MACF1 PDS5A FKBP4 NUP153 | 8.79e-08 | 744 | 158 | 22 | int:SIRT7 |
| Interaction | HDAC1 interactions | IPO5 NOLC1 NRIP1 MYBBP1A MYH10 MYCBP2 CENPF APC ZMYM2 POU2F1 CEP128 BIRC6 JMJD1C ZFHX4 BRCA2 SYNJ1 ZNF592 MYH14 CCDC47 RAB3GAP2 TET1 ARID5B RERE MGA AKAP1 OBI1 PCNA | 1.38e-07 | 1108 | 158 | 27 | int:HDAC1 |
| Interaction | HECTD1 interactions | NOLC1 ZC3H14 NRIP1 MYBBP1A MYH10 SERBP1 MYCBP2 CENPF RBBP6 ATAD5 APC HMMR HUWE1 THOC2 BIRC6 GTF3C3 DECR1 UBAP2L PRRC2C DDX18 MACF1 HSF2 CDC25C AKAP1 PCNA | 1.96e-07 | 984 | 158 | 25 | int:HECTD1 |
| Interaction | SLX4 interactions | PMS1 CWF19L2 SERBP1 ZMYM2 CHD9 REV3L GTF3C3 CCNT1 RESF1 BRD2 BRCA2 CSNK1A1 DDX18 PDS5A POLQ MGA NUP153 PCNA | 5.91e-07 | 572 | 158 | 18 | int:SLX4 |
| Interaction | NAA40 interactions | PMS1 NOLC1 ZC3H14 MYBBP1A MYH10 SERBP1 MYO6 RBBP6 ATAD5 ZMYM2 FAM114A2 ICE1 THOC2 NPLOC4 CCNT1 SYNJ1 UBAP2L PRRC2C YLPM1 MACF1 AKAP1 FKBP4 NUP153 PCNA | 6.61e-07 | 978 | 158 | 24 | int:NAA40 |
| Interaction | YWHAH interactions | NOLC1 ZC3H14 NRIP1 ARHGAP32 CDR2 MYH11 SERBP1 MYCBP2 RALGAPB APC HUWE1 ATAT1 CEP128 RESF1 SYNJ1 SYNJ2 CSNK1A1 PRRC2C RAB3GAP2 TET1 NHS MACF1 CDC25C AKAP1 WNK2 | 1.58e-06 | 1102 | 158 | 25 | int:YWHAH |
| Interaction | SYNE3 interactions | ARHGAP32 VEZT CNOT10 VPS13C APC TNRC6C CEP128 CEP164 BRCA2 CCDC47 CSNK1A1 SECISBP2 MACF1 ERP29 OBI1 | 2.29e-06 | 444 | 158 | 15 | int:SYNE3 |
| Interaction | FAM120C interactions | MYO6 CNOT10 APC TNRC6C UBAP2L PRRC2C MARF1 SECISBP2 AKAP1 FKBP4 | 2.74e-06 | 191 | 158 | 10 | int:FAM120C |
| Interaction | ATOH1 interactions | 3.13e-06 | 80 | 158 | 7 | int:ATOH1 | |
| Interaction | YAP1 interactions | IPO5 ZC3H14 MYH10 MYH11 SERBP1 ANK3 MYO6 RBBP6 FNBP4 THUMPD1 HUWE1 THOC2 JMJD1C GTF3C3 BRD2 MYH14 UBAP2L PRRC2C RAB3GAP2 TET1 YLPM1 MGA NFAT5 PCNA | 4.72e-06 | 1095 | 158 | 24 | int:YAP1 |
| Interaction | NUP43 interactions | RBBP6 APC ZMYM2 CHD9 ICE1 JMJD1C RESF1 BRCA2 ZNF592 PRRC2C RAB3GAP2 DDX18 MARF1 RERE HSF2 MGA NUP153 | 8.67e-06 | 625 | 158 | 17 | int:NUP43 |
| Interaction | EGLN3 interactions | IPO5 ARHGAP32 BMP2K MYCBP2 MYO6 CENPF CNOT10 APC ICE1 HMMR BIRC6 JMJD1C NPLOC4 GTF3C3 CCNT1 BRCA2 UBAP2L CCDC47 CSNK1A1 ARID5B SECISBP2 MGA AKAP1 OBI1 NUP153 PCNA | 8.86e-06 | 1296 | 158 | 26 | int:EGLN3 |
| Interaction | DCAF4 interactions | SECISBP2L IPO5 ARHGAP32 RBBP6 ATAD5 VPS13C APC TNRC6C CEP128 DDX18 MARF1 SECISBP2 FKBP4 | 9.23e-06 | 378 | 158 | 13 | int:DCAF4 |
| Interaction | AR interactions | NRIP1 MYBBP1A MYH10 MYCBP2 MYO6 VPS13C ZMYM2 POU2F1 HUWE1 JMJD1C CCNT1 BRD2 MYH14 UBAP2L CSNK1A1 YLPM1 ARID5B PDS5A PLCG2 RERE MGA FKBP4 | 1.02e-05 | 992 | 158 | 22 | int:AR |
| Interaction | MKRN2 interactions | ZC3H14 MYH10 SERBP1 MYO6 CNOT10 APC TNRC6C SYNJ1 UBAP2L PRRC2C MARF1 SECISBP2 MACF1 | 1.12e-05 | 385 | 158 | 13 | int:MKRN2 |
| Interaction | BRCA1 interactions | IPO5 NOLC1 NRIP1 CWF19L2 MYBBP1A MYH10 CENPF FNBP4 POU2F1 CHD9 HMMR TNRC6C HUWE1 BABAM1 FBXO5 BRCA2 MYH14 UBAP2L ABRAXAS1 PDS5A SAGE1 CDC25C FKBP4 NUP153 PCNA | 1.40e-05 | 1249 | 158 | 25 | int:BRCA1 |
| Interaction | CNOT9 interactions | 1.47e-05 | 231 | 158 | 10 | int:CNOT9 | |
| Interaction | HDAC2 interactions | IPO5 ZC3H14 NRIP1 CDR2 MYBBP1A MYH10 SERBP1 BMP2K MYCBP2 ZMYM2 HMMR HUWE1 JMJD1C BRCA2 CSNK1A1 PRRC2C TET1 ARID5B RERE DMD | 1.48e-05 | 865 | 158 | 20 | int:HDAC2 |
| Interaction | HSPA4 interactions | MYH10 SERBP1 RBBP6 ZMYM2 POU2F1 HUWE1 RHO BRCA2 MYH14 CSNK1A1 ABRAXAS1 POLQ HSF2 CDC25C AKAP1 OBI1 FKBP4 | 2.00e-05 | 667 | 158 | 17 | int:HSPA4 |
| Interaction | POLR1E interactions | NOLC1 CWF19L2 MYBBP1A ATAD5 ICE1 GTF3C3 BRD2 BRCA2 ZNF592 DDX18 TET1 MGA | 2.12e-05 | 350 | 158 | 12 | int:POLR1E |
| Interaction | H3C1 interactions | IPO5 MYBBP1A MYH10 ANK3 MYO6 ATAD5 ZMYM2 JMJD1C GTF3C3 ANKRD18B TLK1 BRD2 XIRP2 MYH14 PRRC2C DDX18 PDS5A BIN2 MGA PCNA | 2.65e-05 | 901 | 158 | 20 | int:H3C1 |
| Interaction | ASF1A interactions | 2.79e-05 | 249 | 158 | 10 | int:ASF1A | |
| Interaction | POLR1G interactions | IPO5 NOLC1 CWF19L2 MYBBP1A ATAD5 CHD9 ICE1 HUWE1 GTF3C3 BRD2 ZNF592 DDX18 PDS5A MGA | 3.22e-05 | 489 | 158 | 14 | int:POLR1G |
| Interaction | LRRC31 interactions | 3.55e-05 | 205 | 158 | 9 | int:LRRC31 | |
| Interaction | CNOT3 interactions | 3.83e-05 | 207 | 158 | 9 | int:CNOT3 | |
| Interaction | LGR4 interactions | MYBBP1A MYH10 MYH11 MYCBP2 FNBP4 THOC2 MYH14 PRRC2C YLPM1 ATP2B2 | 4.30e-05 | 262 | 158 | 10 | int:LGR4 |
| Interaction | SMG7 interactions | SECISBP2L SERBP1 TNRC6C CEP128 JMJD1C UBAP2L TET1 YLPM1 SECISBP2 AKAP1 OBI1 | 4.49e-05 | 319 | 158 | 11 | int:SMG7 |
| Interaction | PKNOX1 interactions | 4.52e-05 | 82 | 158 | 6 | int:PKNOX1 | |
| Interaction | CSNK2A2 interactions | IPO5 NOLC1 SERBP1 ZNF670 MTMR1 HMMR HUWE1 GTF3C3 ANKRD36B BRD2 PIGR CCDC82 ZNF592 PRRC2C PDS5A CDC25C MGA | 5.05e-05 | 718 | 158 | 17 | int:CSNK2A2 |
| Interaction | LZTS2 interactions | CWF19L2 ARHGAP32 ANK3 MYO6 APC TNRC6C HUWE1 CEP128 BIRC6 CEP164 BRCA2 CSNK1A1 MARF1 SECISBP2 | 5.30e-05 | 512 | 158 | 14 | int:LZTS2 |
| Interaction | EED interactions | IPO5 NOLC1 MYBBP1A MYH10 MYH11 BMP2K MYCBP2 MYO6 RBBP6 VPS13C ZMYM2 LMNB2 HUWE1 THOC2 BIRC6 GTF3C3 SYNJ1 PIGR XIRP2 RAB3GAP2 DDX18 YLPM1 MACF1 PDS5A MGA PCNA | 5.73e-05 | 1445 | 158 | 26 | int:EED |
| Interaction | APC interactions | NOLC1 MYH10 MYH11 MYCBP2 MYO6 APC ADGRL1 CEP128 CSNK1A1 MACF1 NUP153 PCNA | 5.92e-05 | 389 | 158 | 12 | int:APC |
| Interaction | R3HDM2 interactions | 7.16e-05 | 129 | 158 | 7 | int:R3HDM2 | |
| Interaction | AP2S1 interactions | 7.51e-05 | 130 | 158 | 7 | int:AP2S1 | |
| Interaction | ANKRD17 interactions | SERBP1 CNOT10 APC TNRC6C UBAP2L CSNK1A1 PRRC2C SECISBP2 OBI1 | 7.56e-05 | 226 | 158 | 9 | int:ANKRD17 |
| Interaction | ANAPC2 interactions | 9.86e-05 | 234 | 158 | 9 | int:ANAPC2 | |
| Interaction | ATG16L1 interactions | IPO5 ZC3H14 CWF19L2 ARHGAP32 MYBBP1A SERBP1 ANK3 MYCBP2 RBBP6 CNOT10 VPS13C FNBP4 APC DECR1 CCDC47 CSNK1A1 PRRC2C YLPM1 SECISBP2 POC5 PLCG2 CCDC102B | 1.09e-04 | 1161 | 158 | 22 | int:ATG16L1 |
| Interaction | NCKAP5 interactions | 1.10e-04 | 32 | 158 | 4 | int:NCKAP5 | |
| Interaction | TERF2IP interactions | PMS1 ZC3H14 CWF19L2 RBBP6 ATAD5 ZMYM2 THOC2 GTF3C3 CCNT1 BABAM1 BRCA2 ZNF592 PDS5A MGA | 1.18e-04 | 552 | 158 | 14 | int:TERF2IP |
| Interaction | FUBP3 interactions | SERBP1 CNOT10 TNRC6C UBAP2L PRRC2C YLPM1 MARF1 SECISBP2 AKAP1 FKBP4 | 1.22e-04 | 297 | 158 | 10 | int:FUBP3 |
| Interaction | PML interactions | PMS1 IPO5 NOLC1 CWF19L2 MYBBP1A MYO6 ZMYM2 HMMR THOC2 JMJD1C GTF3C3 CCNT1 TLK1 PIGR MYH14 UBAP2L LPCAT3 PDS5A PCNA | 1.33e-04 | 933 | 158 | 19 | int:PML |
| Interaction | KLF16 interactions | NOLC1 MYBBP1A SERBP1 ATAD5 POU2F1 HUWE1 GTF3C3 BRD2 PRRC2C DDX18 MGA PCNA | 1.37e-04 | 425 | 158 | 12 | int:KLF16 |
| Interaction | CIT interactions | IPO5 NOLC1 ZC3H14 NRIP1 ARHGAP32 MYBBP1A MYH10 MYH11 SERBP1 MYO6 CENPF RBBP6 LMNB2 THOC2 BIRC6 CSNK1A1L MYH14 UBAP2L PRRC2C DDX18 SECISBP2 MACF1 PDS5A SPAG17 NUP153 | 1.59e-04 | 1450 | 158 | 25 | int:CIT |
| Interaction | CHEK2 interactions | 1.62e-04 | 250 | 158 | 9 | int:CHEK2 | |
| Interaction | KIF23 interactions | IPO5 NOLC1 MYBBP1A MYH10 MYH11 SERBP1 APC CHD9 LMNB2 HMMR HUWE1 THOC2 BIRC6 CSNK1A1L FBXO5 MYH14 CSNK1A1 DDX18 MACF1 DMD | 1.68e-04 | 1031 | 158 | 20 | int:KIF23 |
| Interaction | RAD9A interactions | 1.69e-04 | 66 | 158 | 5 | int:RAD9A | |
| Interaction | PMS1 interactions | 1.79e-04 | 105 | 158 | 6 | int:PMS1 | |
| Interaction | YTHDF2 interactions | SERBP1 BMP2K CNOT10 TNRC6C HUWE1 UBAP2L PRRC2C MARF1 SECISBP2 AKAP1 | 1.82e-04 | 312 | 158 | 10 | int:YTHDF2 |
| Interaction | CSNK2A1 interactions | NOLC1 NRIP1 SERBP1 ZNF670 ATAD5 FNBP4 APC MTMR1 BIRC6 GTF3C3 ANKRD36B BRD2 CCDC82 ZNF592 PRRC2C MACF1 CDC25C MGA FKBP4 | 1.82e-04 | 956 | 158 | 19 | int:CSNK2A1 |
| Interaction | RANGAP1 interactions | PMS1 IPO5 SERBP1 MYCBP2 RGPD1 HUWE1 GTF3C3 BABAM1 CSNK1A1 NUP153 | 1.91e-04 | 314 | 158 | 10 | int:RANGAP1 |
| Interaction | H2BC9 interactions | SECISBP2L MYH10 SERBP1 MYO6 HMMR SERPINI2 ZFHX4 XIRP2 SYNJ2 WBP4 YLPM1 SPAG17 | 2.13e-04 | 446 | 158 | 12 | int:H2BC9 |
| Interaction | KIF20A interactions | IPO5 NOLC1 NRIP1 MYBBP1A MYH10 MYH11 SERBP1 MYO6 RBBP6 ADGRL1 LMNB2 THOC2 CSNK1A1L MYH14 UBAP2L CSNK1A1 DDX18 YLPM1 MACF1 PLCG2 | 2.20e-04 | 1052 | 158 | 20 | int:KIF20A |
| Interaction | KCTD13 interactions | IPO5 ARHGAP32 PDE1C MYBBP1A MYH10 MYH11 SERBP1 ANK3 OXR1 MYO6 APC MTMR1 ADGRL1 BCAS1 SYNJ1 MYH14 UBAP2L CSNK1A1 PRRC2C MACF1 DMD ATP2B2 WNK2 PCNA | 2.23e-04 | 1394 | 158 | 24 | int:KCTD13 |
| Interaction | NR3C1 interactions | NRIP1 ARHGAP32 SERBP1 MYO6 ATAD5 RGPD1 ZMYM2 POU2F1 CHD9 REV3L JMJD1C FER1L6 ANKRD36B CCDC47 WBP4 ARID5B CCDC102B FKBP4 NUP153 | 2.31e-04 | 974 | 158 | 19 | int:NR3C1 |
| Interaction | PRKACA interactions | IPO5 NOLC1 MYBBP1A MYH10 APC POU2F1 HMMR PPP1R17 HUWE1 CEP128 POC5 AKAP1 NFAT5 | 2.34e-04 | 519 | 158 | 13 | int:PRKACA |
| Interaction | CPEB4 interactions | 2.34e-04 | 156 | 158 | 7 | int:CPEB4 | |
| Interaction | GULP1 interactions | 2.67e-04 | 40 | 158 | 4 | int:GULP1 | |
| Interaction | CEBPA interactions | NOLC1 ZC3H14 MYCBP2 ZMYM2 POU2F1 CHD9 HMMR THOC2 JMJD1C CCNT1 TLK1 RESF1 CSNK1A1 PRRC2C RAB3GAP2 DDX18 MACF1 PDS5A ERP29 BIN2 FKBP4 NUP153 | 2.92e-04 | 1245 | 158 | 22 | int:CEBPA |
| Interaction | TP53BP1 interactions | HUWE1 THOC2 JMJD1C NPLOC4 GTF3C3 CCNT1 TLK1 BABAM1 BRCA2 ABRAXAS1 SAGE1 POLQ MGA | 3.02e-04 | 533 | 158 | 13 | int:TP53BP1 |
| Interaction | AURKB interactions | NOLC1 MYBBP1A MYH10 MYH11 SERBP1 MTMR1 HUWE1 GTF3C3 TLK1 BRCA2 MYH14 PRRC2C DDX18 MACF1 AKAP1 OBI1 | 3.27e-04 | 761 | 158 | 16 | int:AURKB |
| Interaction | DUXB interactions | 3.54e-04 | 18 | 158 | 3 | int:DUXB | |
| Interaction | TERF2 interactions | 3.61e-04 | 340 | 158 | 10 | int:TERF2 | |
| Interaction | XRCC6 interactions | MYBBP1A MYH10 SERBP1 RBBP6 POU2F1 ICE1 HUWE1 THOC2 JMJD1C CCNT1 BRCA2 CSNK1A1 WBP4 YLPM1 MGA FKBP4 NUP153 PCNA | 3.64e-04 | 928 | 158 | 18 | int:XRCC6 |
| Interaction | ACTC1 interactions | NOLC1 MYH10 SERBP1 MYO6 CENPF RBBP6 FNBP4 CCNT1 TLK1 SYNJ1 YLPM1 DMD WNK2 NUP153 PCNA | 3.78e-04 | 694 | 158 | 15 | int:ACTC1 |
| Interaction | CEP85 interactions | 3.80e-04 | 169 | 158 | 7 | int:CEP85 | |
| Interaction | DYNLT3 interactions | 3.87e-04 | 44 | 158 | 4 | int:DYNLT3 | |
| Interaction | ENO1 interactions | IPO5 MYH10 MYH11 SERBP1 ANK3 MYO6 CENPF HUWE1 NPLOC4 ANKRD18B FBXO5 MYH14 SYCP1 NHS PCNA | 4.20e-04 | 701 | 158 | 15 | int:ENO1 |
| Interaction | NANOG interactions | MYBBP1A CENPF ZMYM2 HUWE1 JMJD1C GTF3C3 RESF1 BRCA2 CSNK1A1 TET1 ARID5B MGA | 4.22e-04 | 481 | 158 | 12 | int:NANOG |
| Interaction | CTNNA1 interactions | 4.23e-04 | 347 | 158 | 10 | int:CTNNA1 | |
| Interaction | CCND1 interactions | 4.38e-04 | 286 | 158 | 9 | int:CCND1 | |
| Interaction | RMND5A interactions | 4.53e-04 | 174 | 158 | 7 | int:RMND5A | |
| Interaction | RFC2 interactions | 4.53e-04 | 174 | 158 | 7 | int:RFC2 | |
| Interaction | MEN1 interactions | NOLC1 ZC3H14 MYBBP1A MYH10 RBBP6 FNBP4 ZMYM2 THOC2 JMJD1C GTF3C3 CCNT1 BRCA2 ZNF592 MYH14 DDX18 YLPM1 PDS5A RERE NUP153 | 4.57e-04 | 1029 | 158 | 19 | int:MEN1 |
| Interaction | TOP3B interactions | IPO5 MYH10 MYCBP2 MYO6 CENPF CNOT10 ADGRL1 PANX1 ICE1 LMNB2 TNRC6C HUWE1 REV3L THOC2 BIRC6 TLK1 BRD2 SYNJ1 ZNF592 UBAP2L CSNK1A1 LRP4 SECISBP2 WNK2 | 4.83e-04 | 1470 | 158 | 24 | int:TOP3B |
| Interaction | WDR48 interactions | 5.02e-04 | 177 | 158 | 7 | int:WDR48 | |
| Interaction | CNOT2 interactions | 5.19e-04 | 178 | 158 | 7 | int:CNOT2 | |
| Interaction | POLH interactions | 5.21e-04 | 84 | 158 | 5 | int:POLH | |
| Interaction | LYN interactions | IPO5 ARHGAP32 MYBBP1A ANK3 MYO6 CNOT10 APC MTMR1 ADGRL1 ADCY3 BRD2 DDX18 MACF1 PLCG2 DMD | 5.54e-04 | 720 | 158 | 15 | int:LYN |
| GeneFamily | Myosin heavy chains | 6.70e-05 | 15 | 98 | 3 | 1098 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.30e-04 | 6 | 98 | 2 | 1328 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.55e-04 | 181 | 98 | 6 | 694 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 6.00e-04 | 7 | 98 | 2 | 1350 | |
| GeneFamily | Phosphoinositide phosphatases | 6.83e-04 | 32 | 98 | 3 | 1079 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.27e-03 | 10 | 98 | 2 | 53 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.54e-03 | 115 | 98 | 4 | 769 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L PMS1 ZC3H14 NRIP1 BMP2K MYCBP2 CENPF APC ZMYM2 CHD9 HMMR REV3L THOC2 TLK1 BRCA2 SYNJ2 CSNK1A1 PRRC2C WBP4 ARID5B MACF1 PDS5A DMD NUP153 PLCE1 | 7.56e-11 | 856 | 159 | 25 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L IPO5 ZC3H14 CDR2 OXR1 BMP2K RBBP6 MGAT4A APC ZMYM2 THUMPD1 MTMR1 CHD9 THOC2 CREBL2 DECR1 UBAP2L CCDC47 CSNK1A1 LPCAT3 RAB3GAP2 WBP4 MACF1 HSF2 NFAT5 RAD17 | 2.10e-08 | 1215 | 159 | 26 | M41122 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | IPO5 NRIP1 CWF19L2 MYH10 MYCBP2 MYO6 VPS13C MGAT4A APC HMMR REV3L RESF1 BCAP29 CCDC47 WBP4 POLQ OBI1 RAD17 | 1.07e-07 | 656 | 159 | 18 | M18979 |
| Coexpression | GABRIELY_MIR21_TARGETS | MYCBP2 MGAT4A APC ZMYM2 REV3L THOC2 ADGRG2 RAB3GAP2 TET1 DMD MGA NFAT5 | 2.17e-07 | 289 | 159 | 12 | M2196 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | BMP2K CENPF ATAD5 SGCB VPS13C APC POU2F1 PANX1 LMNB2 HMMR CEP128 CREBL2 FBXO5 BRCA2 CCDC47 MACF1 POLQ OBI1 PLCE1 | 2.15e-06 | 892 | 159 | 19 | M18120 |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 3.88e-06 | 200 | 159 | 9 | M4622 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP | 3.88e-06 | 200 | 159 | 9 | M5168 | |
| Coexpression | HEIDENBLAD_AMPLICON_8Q24_UP | 4.84e-06 | 41 | 159 | 5 | M18260 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 4.97e-06 | 155 | 159 | 8 | M39041 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | PMS1 IPO5 NOLC1 MYBBP1A SERBP1 CENPF HMMR HUWE1 GTF3C3 FBXO5 BRCA2 CCDC47 DDX18 CDC25C NUP153 | 5.18e-06 | 612 | 159 | 15 | M4772 |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 5.73e-06 | 158 | 159 | 8 | M372 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PMS1 NRIP1 MYCBP2 CENPF ZMYM2 CHD9 REV3L TLK1 PRRC2C ARID5B MARF1 PDS5A NUP153 | 5.75e-06 | 466 | 159 | 13 | M13522 |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 7.51e-06 | 117 | 159 | 7 | M7854 | |
| Coexpression | GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN | 9.80e-06 | 170 | 159 | 8 | M8188 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 1.16e-05 | 174 | 159 | 8 | M6881 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 1.42e-05 | 129 | 159 | 7 | M41687 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | SECISBP2L CWF19L2 CDR2 ANK3 MGAT4A FNBP4 ZMYM2 THOC2 CCNT1 PRRC2C HSF2 | 1.44e-05 | 363 | 159 | 11 | M41103 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | PMS1 NRIP1 ANK3 OXR1 VEZT MGAT4A ZMYM2 THUMPD1 ICE1 CREBL2 ANKRD36B SETDB2 TLK1 DDX18 PCNA | 2.02e-05 | 687 | 159 | 15 | M41022 |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.05e-05 | 27 | 159 | 4 | M2483 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.38e-05 | 28 | 159 | 4 | MM1323 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 2.74e-05 | 196 | 159 | 8 | M4940 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN | 3.05e-05 | 199 | 159 | 8 | M9283 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 3.17e-05 | 200 | 159 | 8 | M4979 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 3.17e-05 | 200 | 159 | 8 | M5059 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 3.17e-05 | 200 | 159 | 8 | M5901 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYCBP2 RBBP6 VPS13C MGAT4A RALGAPB FNBP4 ICE1 TNRC6C HUWE1 REV3L BIRC6 ZC3H6 JMJD1C TLK1 RESF1 RAB3GAP2 SECISBP2 MACF1 PDS5A BIN2 NFAT5 NUP153 SP140 | 3.56e-05 | 1492 | 159 | 23 | M40023 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | CWF19L2 CDR2 MYBBP1A SERBP1 CENPF ATAD5 HMMR TLK1 FBXO5 BRCA2 LRFN5 DDX18 SYCP1 PDS5A POC5 POLQ HSF2 CDC25C OBI1 NUP153 PCNA | 3.69e-05 | 1290 | 159 | 21 | M80 |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 4.48e-05 | 272 | 159 | 9 | M15123 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 6.41e-05 | 221 | 159 | 8 | M39222 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 7.37e-05 | 37 | 159 | 4 | MM570 | |
| Coexpression | GARY_CD5_TARGETS_DN | IPO5 NOLC1 SERBP1 BMP2K CENPF ICE1 FBXO5 UBAP2L DDX18 WBP4 SP140 | 8.23e-05 | 440 | 159 | 11 | M13893 |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 CDR2 CENPF RBBP6 ATAD5 FNBP4 POU2F1 HMMR BIRC6 FBXO5 BRCA2 POC5 POLQ CDC25C OBI1 NUP153 PCNA | 8.76e-05 | 969 | 159 | 17 | M149 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.50e-05 | 300 | 159 | 9 | M8702 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 9.98e-05 | 175 | 159 | 7 | M2940 | |
| Coexpression | PILON_KLF1_TARGETS_UP | ANK3 BMP2K RALGAPB HUWE1 CCNT1 TLK1 CSNK1A1L RESF1 KMT5B CSNK1A1 FCN2 KEL | 1.21e-04 | 541 | 159 | 12 | MM1061 |
| Coexpression | SU_TESTIS | 1.28e-04 | 80 | 159 | 5 | M9746 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 1.32e-04 | 183 | 159 | 7 | M2993 | |
| Coexpression | WHITFIELD_CELL_CYCLE_LITERATURE | 1.47e-04 | 44 | 159 | 4 | M2066 | |
| Coexpression | YAGI_AML_WITH_T_9_11_TRANSLOCATION | 1.52e-04 | 131 | 159 | 6 | M16922 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | SECISBP2L MYH10 CENPF ICE1 SYNJ2 CCDC47 FCN2 LPCAT3 YLPM1 RERE | 1.70e-04 | 399 | 159 | 10 | M40939 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.81e-04 | 402 | 159 | 10 | MM454 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | ADCY10 SERBP1 OXR1 BMP2K MYO6 NPAS3 ZMYM2 ANKRD36B ADGRG2 DMD | 1.88e-04 | 404 | 159 | 10 | M19488 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 1.89e-04 | 194 | 159 | 7 | M7313 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NOLC1 NRIP1 MYBBP1A CHD9 TLK1 CSNK1A1L UBAP2L CSNK1A1 PRRC2C ARID5B FKBP4 | 1.89e-04 | 484 | 159 | 11 | MM999 |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 2.21e-04 | 199 | 159 | 7 | M5970 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 2.26e-04 | 141 | 159 | 6 | M7720 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN | 2.27e-04 | 200 | 159 | 7 | M9486 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | 2.27e-04 | 200 | 159 | 7 | M9357 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN | 2.27e-04 | 200 | 159 | 7 | M8572 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 2.27e-04 | 200 | 159 | 7 | M6447 | |
| Coexpression | GSE3982_DC_VS_MAC_LPS_STIM_UP | 2.27e-04 | 200 | 159 | 7 | M5387 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_DN | 2.27e-04 | 200 | 159 | 7 | M6779 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 2.27e-04 | 200 | 159 | 7 | M9260 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | NOLC1 NRIP1 MYH10 SERBP1 CENPF LMNB2 HMMR LPCAT3 DDX18 ARID5B POLQ CDC25C FKBP4 | 2.32e-04 | 669 | 159 | 13 | M18635 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | IPO5 NOLC1 CENPF RBBP6 LMNB2 HMMR BRCA2 UBAP2L PRRC2C DDX18 PDS5A PLCG2 NUP153 PCNA | 2.33e-04 | 761 | 159 | 14 | M11961 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.43e-04 | 417 | 159 | 10 | M39224 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 2.54e-04 | 144 | 159 | 6 | M335 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | PDE1C OXR1 HMMR CEP128 ADCY3 FBXO5 BRCA2 C8orf76 POLQ CDC25C PCNA SP140 | 2.60e-04 | 588 | 159 | 12 | M38992 |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 2.73e-04 | 146 | 159 | 6 | M9372 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NOLC1 SERBP1 RBBP6 RALGAPB FNBP4 APC MTMR1 ICE1 HMMR THOC2 UBAP2L PRRC2C RAB3GAP2 DDX18 ALPK3 PDS5A PLCG2 NUP153 PCNA SP140 | 3.09e-04 | 1394 | 159 | 20 | M9585 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | OXR1 MYO6 SGCB FNBP4 ADGRL1 REV3L PDE10A ADCY3 JMJD1C DECR1 PRRC2C MACF1 PDS5A PCNA | 3.40e-04 | 790 | 159 | 14 | M12490 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | PMS1 IPO5 NOLC1 CENPF VEZT LMNB2 HMMR GTF3C3 CCNT1 FBXO5 BRCA2 UBAP2L PRRC2C DDX18 TET1 DMD POLQ CDC25C FKBP4 PCNA | 3.49e-04 | 1407 | 159 | 20 | M14427 |
| Coexpression | ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR | 3.65e-04 | 100 | 159 | 5 | M39212 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | PMS1 IPO5 CENPF ATAD5 CNOT10 LMNB2 HMMR CEP128 ZUP1 ANKRD36B FBXO5 BRCA2 WBP4 C8orf76 POC5 POLQ CDC25C NUP153 PCNA RAD17 | 4.03e-04 | 1423 | 159 | 20 | M45722 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L ANK3 MYCBP2 NPAS3 APC FAM114A2 ADGRL1 POU2F1 TNRC6C REV3L ANKRD36B ZFHX4 SYNJ1 LRFN5 SPAG17 ATP2B2 SH3BP5 | 4.14e-04 | 1106 | 159 | 17 | M39071 |
| Coexpression | GALE_APL_WITH_FLT3_MUTATED_UP | 4.58e-04 | 59 | 159 | 4 | M3845 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | PMS1 OXR1 CENPF RBBP6 RALGAPB APC MTMR1 HMMR THOC2 TLK1 RESF1 BRCA2 CSNK1A1 | 4.73e-04 | 721 | 159 | 13 | M10237 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP | 5.01e-04 | 228 | 159 | 7 | M2151 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN | 5.08e-04 | 164 | 159 | 6 | M2972 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 5.12e-04 | 300 | 159 | 8 | M45675 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 5.12e-04 | 300 | 159 | 8 | M39059 | |
| Coexpression | KAUFFMANN_MELANOMA_RELAPSE_UP | 5.20e-04 | 61 | 159 | 4 | M2431 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 5.41e-04 | 166 | 159 | 6 | M8129 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PMS1 NOLC1 CWF19L2 MYH10 SERBP1 CENPF RBBP6 ATAD5 APC ZMYM2 POU2F1 CHD9 HMMR REV3L THOC2 CEP128 ZUP1 BCLAF3 FBXO5 BRCA2 MYH14 ABRAXAS1 TET1 MACF1 PDS5A DMD HSF2 CDC25C OBI1 PCNA | 7.68e-09 | 1257 | 155 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | NRIP1 SERBP1 ANK3 MYCBP2 MGAT4A RALGAPB APC MTMR1 TNRC6C HUWE1 REV3L BIRC6 CSNK1A1 PRRC2C NFAT5 | 1.11e-07 | 375 | 155 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PMS1 NOLC1 CWF19L2 MYH10 SERBP1 CENPF RBBP6 ATAD5 APC ZMYM2 POU2F1 CHD9 HMMR REV3L THOC2 CEP128 ZUP1 BCLAF3 FBXO5 BRCA2 MYH14 ABRAXAS1 TET1 MACF1 PDS5A DMD HSF2 CDC25C OBI1 PCNA | 2.09e-07 | 1459 | 155 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | ANK3 MYCBP2 MGAT4A APC MTMR1 TNRC6C HUWE1 REV3L CSNK1A1 PRRC2C NFAT5 | 2.74e-07 | 201 | 155 | 11 | gudmap_developingKidney_e15.5_500_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | NRIP1 MYCBP2 VEZT MGAT4A APC HUWE1 REV3L ZC3H6 CSNK1A1 NFAT5 | 3.40e-07 | 163 | 155 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | PMS1 MYBBP1A CENPF MGAT4A HMMR TNRC6C ZC3H6 GTF3C3 BCLAF3 SETDB2 SYCP2 BRCA2 BCAP29 ABRAXAS1 DDX18 TET1 SYCP1 C8orf76 HSF2 MGA RAD17 | 4.74e-07 | 810 | 155 | 21 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | MYH10 NWD1 ATAD5 APC ZMYM2 REV3L BCLAF3 ZFHX4 BRCA2 ABRAXAS1 TET1 YLPM1 MACF1 KEL MGA | 6.75e-07 | 432 | 155 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ANK3 MYCBP2 VEZT MGAT4A FNBP4 APC MTMR1 HUWE1 REV3L BIRC6 PRRC2C SECISBP2 MGA NFAT5 | 7.79e-07 | 379 | 155 | 14 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CDR2 MYH10 CENPF ATAD5 APC ZMYM2 POU2F1 CHD9 BCLAF3 BRCA2 UBAP2L ABRAXAS1 TET1 YLPM1 MACF1 DMD HSF2 MGA | 8.29e-07 | 629 | 155 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CWF19L2 SERBP1 MYO6 CENPF ATAD5 APC POU2F1 CCNT1 SETDB2 BRCA2 MYH14 PRRC2C TET1 PDS5A CDC25C | 1.87e-06 | 469 | 155 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | PMS1 CWF19L2 PDE1C CENPF ATAD5 APC ZMYM2 MTMR1 CHD9 HMMR REV3L ZUP1 TLK1 FBXO5 BRCA2 SYNJ1 MYH14 ABRAXAS1 WBP4 NHS RERE DMD HSF2 CDC25C OBI1 WNK2 PLCE1 | 2.11e-06 | 1370 | 155 | 27 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 2.34e-06 | 117 | 155 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | NRIP1 ARHGAP32 SERBP1 ANK3 MYCBP2 MYO6 VEZT MGAT4A RALGAPB APC MTMR1 TNRC6C HUWE1 REV3L BIRC6 ZC3H6 CSNK1A1 PRRC2C NFAT5 | 3.87e-06 | 774 | 155 | 19 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | CDR2 MYCBP2 ATAD5 APC FAM114A2 POU2F1 CHD9 ICE1 THOC2 CEP128 JMJD1C UBAP2L YLPM1 MACF1 HSF2 PCNA | 3.93e-06 | 564 | 155 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | PMS1 NOLC1 MYBBP1A CENPF MGAT4A HMMR GTF3C3 BCLAF3 SETDB2 SYCP2 FBXO5 BRCA2 BCAP29 DDX18 TET1 SYCP1 PLCG2 HSF2 NUP153 | 5.68e-06 | 795 | 155 | 19 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NRIP1 CWF19L2 CHD9 HMMR HUWE1 PDE10A THOC2 BIRC6 JMJD1C RESF1 ZFHX4 UBAP2L CSNK1A1 PRRC2C TET1 ARID5B MGA NFAT5 NUP153 | 6.67e-06 | 804 | 155 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NRIP1 FNBP4 CHD9 HMMR PPP1R17 PDE10A THOC2 BIRC6 JMJD1C RESF1 BRD2 ZFHX4 UBAP2L PRRC2C TET1 ARID5B MGA OBI1 NUP153 | 8.08e-06 | 815 | 155 | 19 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | PDE1C ANK3 MYCBP2 VEZT MGAT4A APC MTMR1 TNRC6C HUWE1 REV3L CSNK1A1 PRRC2C NFAT5 | 8.33e-06 | 402 | 155 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NOLC1 CWF19L2 MYH10 SERBP1 ANK3 CENPF ATAD5 APC ZMYM2 CHD9 PDE10A THOC2 ZUP1 SETDB2 RESF1 FBXO5 BRCA2 MYH14 ABRAXAS1 NHS MACF1 HSF2 CDC25C RAD17 | 1.15e-05 | 1241 | 155 | 24 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CWF19L2 MYH10 CENPF ATAD5 APC ZMYM2 CHD9 BCAS1 HMMR REV3L THOC2 CEP128 ZUP1 BCLAF3 RESF1 FBXO5 BRCA2 MYH14 UBAP2L ABRAXAS1 TET1 YLPM1 NHS HSF2 | 1.33e-05 | 1252 | 155 | 24 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.62e-05 | 152 | 155 | 8 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | ANK3 MYCBP2 MGAT4A APC REV3L BIRC6 CEP164 PRRC2C SECISBP2 NFAT5 | 2.28e-05 | 261 | 155 | 10 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | PMS1 MYBBP1A CENPF MGAT4A GTF3C3 BCLAF3 SYCP2 BRCA2 BCAP29 TET1 SYCP1 HSF2 | 3.54e-05 | 396 | 155 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | MYH10 NWD1 CENPF ATAD5 APC ZMYM2 POU2F1 REV3L BCLAF3 FBXO5 ZFHX4 BRCA2 MYH14 ABRAXAS1 TET1 YLPM1 MACF1 KEL MGA ATP2B2 | 3.58e-05 | 989 | 155 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CWF19L2 SERBP1 CENPF ATAD5 VPS13C POU2F1 PDE10A BIRC6 BRCA2 PRRC2C ABRAXAS1 LRP4 PDS5A POLQ | 3.71e-05 | 532 | 155 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | ANK3 CENPF MGAT4A APC REV3L BIRC6 CEP164 TLK1 RESF1 PRRC2C NFAT5 | 4.09e-05 | 339 | 155 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | NOLC1 NRIP1 ARHGAP32 MYBBP1A FNBP4 LMNB2 HMMR ATAT1 BIRC6 CCNT1 TLK1 RESF1 BRD2 ZFHX4 UBAP2L MGA NFAT5 OBI1 | 4.59e-05 | 844 | 155 | 18 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NRIP1 CHD9 HUWE1 PDE10A THOC2 BIRC6 JMJD1C SETDB2 SYCP2 RESF1 BRCA2 SYNJ1 UBAP2L SYCP1 MGA NFAT5 NUP153 | 5.44e-05 | 776 | 155 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | ARHGAP32 CDR2 CENPF ATAD5 HMMR CEP128 FBXO5 BRCA2 TET1 KEL POLQ CDC25C | 6.10e-05 | 419 | 155 | 12 | GSM538348_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | PDE1C ANK3 MYCBP2 VEZT MGAT4A FNBP4 APC MTMR1 TNRC6C HUWE1 REV3L BIRC6 CSNK1A1 PRRC2C SECISBP2 MGA NFAT5 | 7.32e-05 | 795 | 155 | 17 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 FNBP4 CHD9 HMMR PDE10A THOC2 BIRC6 JMJD1C TLK1 RESF1 BRD2 ADGRG2 PRRC2C TET1 ARID5B MGA NFAT5 | 8.02e-05 | 801 | 155 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CWF19L2 CENPF RBBP6 ATAD5 ZMYM2 POU2F1 REV3L BRCA2 PDS5A POLQ | 9.93e-05 | 311 | 155 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.00e-04 | 146 | 155 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | NRIP1 CHD9 PDE10A THOC2 JMJD1C PRRC2C TET1 ARID5B OBI1 NUP153 | 1.35e-04 | 323 | 155 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | NOLC1 NRIP1 ARHGAP32 MYBBP1A POU2F1 LMNB2 HMMR ATAT1 CEP164 CCNT1 RESF1 BRD2 ZFHX4 UBAP2L PRRC2C MGA OBI1 | 1.48e-04 | 843 | 155 | 17 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CWF19L2 SERBP1 CENPF RBBP6 ATAD5 VPS13C KIAA0825 LRP4 DMD POLQ | 1.53e-04 | 328 | 155 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.57e-04 | 110 | 155 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NOLC1 CWF19L2 MYH10 SERBP1 ANK3 CENPF ATAD5 APC ZMYM2 CHD9 PDE10A THOC2 ZUP1 SETDB2 RESF1 FBXO5 BRCA2 MYH14 ABRAXAS1 NHS MACF1 HSF2 CDC25C RAD17 | 1.64e-04 | 1468 | 155 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | PDE1C MYH11 SERBP1 MYCBP2 SGCB NPAS3 APC HUWE1 REV3L ZFHX4 KMT5B CSNK1A1 PRRC2C LRFN5 AKAP1 NFAT5 | 1.72e-04 | 772 | 155 | 16 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | CENPF HMMR TNRC6C GTF3C3 BCLAF3 BCAP29 ABRAXAS1 C8orf76 HSF2 RAD17 | 1.73e-04 | 333 | 155 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 NOLC1 MYBBP1A CENPF HMMR BCLAF3 SYCP2 FBXO5 BRCA2 BCAP29 DDX18 TET1 PLCG2 HSF2 AKAP1 NUP153 | 1.96e-04 | 781 | 155 | 16 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | ARHGAP32 MYH10 CENPF ATAD5 HMMR FBXO5 BRCA2 TET1 ALPK3 POLQ CDC25C | 2.19e-04 | 410 | 155 | 11 | GSM791122_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NRIP1 FNBP4 CHD9 HMMR PDE10A THOC2 BIRC6 JMJD1C RESF1 BRD2 ADGRG2 PRRC2C TET1 ARID5B MGA NFAT5 | 2.23e-04 | 790 | 155 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | NRIP1 FNBP4 CHD9 PDE10A THOC2 BIRC6 ZUP1 SYCP2 RESF1 BRD2 SYNJ1 ADGRG2 PRRC2C SYCP1 MGA NFAT5 | 2.40e-04 | 795 | 155 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 2.67e-04 | 78 | 155 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.83e-04 | 79 | 155 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.85e-04 | 173 | 155 | 7 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | ARHGAP32 MYH10 CENPF ATAD5 HMMR CEP128 BRCA2 TET1 KEL POLQ CDC25C | 2.86e-04 | 423 | 155 | 11 | GSM791126_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CWF19L2 SERBP1 CENPF RBBP6 ATAD5 VPS13C NPAS3 MTMR1 POU2F1 PDE10A BRCA2 KIAA0825 LRP4 NHS DMD POLQ ATP2B2 WNK2 | 3.07e-04 | 983 | 155 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | PMS1 CENPF HMMR GTF3C3 BCLAF3 SETDB2 SYCP2 FBXO5 BRCA2 BCAP29 ABRAXAS1 TET1 SYCP1 PLCG2 HSF2 AKAP1 | 3.47e-04 | 822 | 155 | 16 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CWF19L2 ARHGAP32 SERBP1 CENPF RBBP6 ATAD5 NPAS3 ZMYM2 HUWE1 CEP164 ZUP1 BRCA2 PDS5A RERE DMD POLQ | 3.91e-04 | 831 | 155 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_100 | 5.22e-04 | 5 | 155 | 2 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.34e-04 | 192 | 155 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | NRIP1 MYCBP2 VEZT MGAT4A APC HUWE1 REV3L ZC3H6 CSNK1A1 NFAT5 | 6.03e-04 | 390 | 155 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 6.06e-04 | 53 | 155 | 4 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200 | 7.45e-04 | 147 | 155 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NRIP1 MYH11 MYO6 FNBP4 CHD9 THOC2 BIRC6 RESF1 BRD2 ADGRG2 PRRC2C TET1 ARID5B UNC13C MGA | 7.53e-04 | 797 | 155 | 15 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.65e-04 | 204 | 155 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 NOLC1 MYBBP1A CENPF HMMR GTF3C3 BCLAF3 FBXO5 BRCA2 BCAP29 DDX18 TET1 PLCG2 HSF2 AKAP1 | 7.73e-04 | 799 | 155 | 15 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NRIP1 MYH11 FNBP4 CHD9 HMMR THOC2 BIRC6 JMJD1C RESF1 BRD2 ADGRG2 PRRC2C TET1 ARID5B MGA | 7.73e-04 | 799 | 155 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 7.91e-04 | 404 | 155 | 10 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.99e-04 | 149 | 155 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 8.36e-04 | 407 | 155 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 CWF19L2 SERBP1 CENPF RBBP6 ATAD5 NPAS3 ZMYM2 POU2F1 REV3L PDE10A BRCA2 PDS5A DMD POLQ ATP2B2 WNK2 | 9.21e-04 | 989 | 155 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 9.35e-04 | 413 | 155 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | NOLC1 ARHGAP32 MYBBP1A FNBP4 POU2F1 HMMR HUWE1 BIRC6 CEP164 CCNT1 RESF1 BRD2 UBAP2L MGA NFAT5 | 9.91e-04 | 819 | 155 | 15 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 CENPF HUWE1 ZC3H6 BCLAF3 SETDB2 SYCP2 BRCA2 BCAP29 ABRAXAS1 TET1 SYCP1 PLCG2 HSF2 MGA | 1.00e-03 | 820 | 155 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | ARHGAP32 CENPF ATAD5 HMMR FBXO5 BRCA2 TET1 POLQ CDC25C FKBP4 | 1.02e-03 | 418 | 155 | 10 | GSM538350_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | NOLC1 NRIP1 MYBBP1A POU2F1 LMNB2 HMMR CEP164 CCNT1 UBAP2L PRRC2C OBI1 | 1.10e-03 | 498 | 155 | 11 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | PMS1 IPO5 NOLC1 NRIP1 TSGA13 MYBBP1A CENPF ATAD5 SGCB MTMR1 ADGRL1 CHD9 ADCY3 GTF3C3 FBXO5 CCDC82 HSF2 MGA FKBP4 WNK2 NUP153 PCNA | 1.12e-03 | 1479 | 155 | 22 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.16e-03 | 160 | 155 | 6 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.31e-03 | 164 | 155 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | NRIP1 ARHGAP32 MYBBP1A LMNB2 HMMR BRD2 ZFHX4 UBAP2L MGA OBI1 | 1.38e-03 | 435 | 155 | 10 | gudmap_developingGonad_e11.5_testes and mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | NRIP1 ARHGAP32 MYBBP1A LMNB2 HMMR BRD2 ZFHX4 UBAP2L MGA OBI1 | 1.43e-03 | 437 | 155 | 10 | gudmap_developingGonad_e11.5_testes_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.55e-03 | 68 | 155 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.59e-03 | 298 | 155 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.61e-03 | 232 | 155 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_200 | 1.62e-03 | 32 | 155 | 3 | gudmap_developingKidney_e15.5_Medullary collecting duct_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | NOLC1 ARHGAP32 MYBBP1A FNBP4 POU2F1 HMMR CEP164 CCNT1 UBAP2L MGA NFAT5 | 1.65e-03 | 524 | 155 | 11 | gudmap_developingGonad_e12.5_testes_k1_1000 |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-09 | 189 | 159 | 10 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.26e-09 | 195 | 159 | 10 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-09 | 195 | 159 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.37e-09 | 196 | 159 | 10 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.37e-09 | 196 | 159 | 10 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.49e-09 | 197 | 159 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.49e-09 | 197 | 159 | 10 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.89e-09 | 200 | 159 | 10 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-09 | 200 | 159 | 10 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-08 | 180 | 159 | 9 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-08 | 184 | 159 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-08 | 187 | 159 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SECISBP2L NRIP1 BMP2K VPS13C CHD9 KMT5B CSNK1A1 PRRC2C PDS5A | 3.05e-08 | 191 | 159 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-08 | 191 | 159 | 9 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SECISBP2L NRIP1 BMP2K VPS13C CHD9 KMT5B CSNK1A1 PRRC2C PDS5A | 3.05e-08 | 191 | 159 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SECISBP2L NRIP1 BMP2K VPS13C CHD9 KMT5B CSNK1A1 PRRC2C PDS5A | 3.05e-08 | 191 | 159 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.33e-08 | 193 | 159 | 9 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.48e-08 | 194 | 159 | 9 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.64e-08 | 195 | 159 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-08 | 195 | 159 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.81e-08 | 196 | 159 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.81e-08 | 196 | 159 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-08 | 199 | 159 | 9 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.34e-08 | 199 | 159 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 4.53e-08 | 200 | 159 | 9 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 4.53e-08 | 200 | 159 | 9 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-08 | 200 | 159 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.97e-08 | 157 | 159 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 167 | 159 | 8 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-07 | 169 | 159 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-07 | 176 | 159 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 179 | 159 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 179 | 159 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-07 | 182 | 159 | 8 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-07 | 182 | 159 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-07 | 182 | 159 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-07 | 182 | 159 | 8 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 159 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 159 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 159 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.50e-07 | 185 | 159 | 8 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.50e-07 | 185 | 159 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-07 | 185 | 159 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.65e-07 | 186 | 159 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.65e-07 | 186 | 159 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-07 | 187 | 159 | 8 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-07 | 189 | 159 | 8 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-07 | 189 | 159 | 8 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-07 | 190 | 159 | 8 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.29e-07 | 190 | 159 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.47e-07 | 191 | 159 | 8 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.47e-07 | 191 | 159 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 4.47e-07 | 191 | 159 | 8 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-07 | 193 | 159 | 8 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-07 | 194 | 159 | 8 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.03e-07 | 194 | 159 | 8 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 5.03e-07 | 194 | 159 | 8 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 5.03e-07 | 194 | 159 | 8 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.03e-07 | 194 | 159 | 8 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-07 | 194 | 159 | 8 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.03e-07 | 194 | 159 | 8 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-07 | 194 | 159 | 8 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 5.22e-07 | 195 | 159 | 8 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 5.22e-07 | 195 | 159 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 5.22e-07 | 195 | 159 | 8 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.43e-07 | 196 | 159 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 5.43e-07 | 196 | 159 | 8 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 5.43e-07 | 196 | 159 | 8 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.64e-07 | 197 | 159 | 8 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.64e-07 | 197 | 159 | 8 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-07 | 197 | 159 | 8 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 5.64e-07 | 197 | 159 | 8 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 5.64e-07 | 197 | 159 | 8 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 5.64e-07 | 197 | 159 | 8 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.64e-07 | 197 | 159 | 8 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.64e-07 | 197 | 159 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.64e-07 | 197 | 159 | 8 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 5.64e-07 | 197 | 159 | 8 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 5.86e-07 | 198 | 159 | 8 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 5.86e-07 | 198 | 159 | 8 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.86e-07 | 198 | 159 | 8 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 5.86e-07 | 198 | 159 | 8 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 5.86e-07 | 198 | 159 | 8 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.86e-07 | 198 | 159 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-07 | 198 | 159 | 8 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.86e-07 | 198 | 159 | 8 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.09e-07 | 199 | 159 | 8 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 6.09e-07 | 199 | 159 | 8 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 6.09e-07 | 199 | 159 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 6.09e-07 | 199 | 159 | 8 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 6.09e-07 | 199 | 159 | 8 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-07 | 199 | 159 | 8 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.09e-07 | 199 | 159 | 8 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 6.09e-07 | 199 | 159 | 8 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 6.09e-07 | 199 | 159 | 8 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.09e-07 | 199 | 159 | 8 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-07 | 199 | 159 | 8 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.09e-07 | 199 | 159 | 8 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-07 | 199 | 159 | 8 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 6.09e-07 | 199 | 159 | 8 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| Computational | Genes in the cancer module 331. | 9.05e-06 | 75 | 107 | 7 | MODULE_331 | |
| Computational | Neighborhood of SMC4L1 | 1.83e-04 | 84 | 107 | 6 | GNF2_SMC4L1 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | NRIP1 MYH10 MYCBP2 MYO6 RBBP6 THUMPD1 THOC2 PRRC2C DDX18 AKAP1 SH3BP5 | 4.90e-08 | 177 | 159 | 11 | 985_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | SECISBP2L NOLC1 NRIP1 PDE1C MYH10 MYO6 ZMYM2 MTMR1 PRRC2C NFAT5 | 8.54e-07 | 188 | 159 | 10 | 6735_DN |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | SECISBP2L NOLC1 BMP2K ATAD5 ZMYM2 CCNT1 BCAP29 PRRC2C NFAT5 SH3BP5 | 8.96e-07 | 189 | 159 | 10 | 1288_DN |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | IPO5 CENPF VPS13C THUMPD1 MTMR1 LMNB2 CREBL2 RESF1 PLCG2 AKAP1 | 1.19e-06 | 195 | 159 | 10 | 1108_UP |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 3.34e-06 | 171 | 159 | 9 | 7535_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.85e-06 | 179 | 159 | 9 | 4585_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.56e-06 | 182 | 159 | 9 | 3887_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.07e-06 | 184 | 159 | 9 | 2321_DN | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A | 6.07e-06 | 184 | 159 | 9 | 3691_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.34e-06 | 185 | 159 | 9 | 1673_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A | 8.56e-06 | 192 | 159 | 9 | 4267_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 9.31e-06 | 194 | 159 | 9 | 4272_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A | 9.31e-06 | 194 | 159 | 9 | 1947_DN | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.05e-05 | 197 | 159 | 9 | 7512_DN | |
| Drug | milrinone | 1.08e-05 | 150 | 159 | 8 | CID000004197 | |
| Drug | DL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 1.10e-05 | 198 | 159 | 9 | 1121_UP | |
| Drug | 2-(aminomethyl)pyrrolidine | 1.80e-05 | 161 | 159 | 8 | CID000072032 | |
| Drug | AC1OA6HT | 1.82e-05 | 8 | 159 | 3 | CID005493749 | |
| Drug | papaverine | 3.42e-05 | 176 | 159 | 8 | CID000004680 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.70e-05 | 178 | 159 | 8 | 3998_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 4.34e-05 | 182 | 159 | 8 | 7085_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 4.34e-05 | 182 | 159 | 8 | 7067_DN | |
| Drug | K-Cl | MYH10 MYH11 CALCB MYO6 SGCB REV3L ADCY3 DECR1 CSNK1A1L MYH14 CSNK1A1 POLQ HSF2 ATP2B2 | 4.63e-05 | 567 | 159 | 14 | CID000004873 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.25e-05 | 187 | 159 | 8 | 4302_DN | |
| Drug | testosterone enanthate | ADCY10 PDE1C MYH11 SERBP1 ANK3 BMP2K PDE10A ADCY3 BRD2 PRRC2C SYCP1 MACF1 NFAT5 FKBP4 | 5.38e-05 | 575 | 159 | 14 | ctd:C004648 |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 5.66e-05 | 189 | 159 | 8 | 4271_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 5.66e-05 | 189 | 159 | 8 | 5203_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 5.88e-05 | 190 | 159 | 8 | 4507_DN | |
| Drug | Daunorubicin hydrochloride [23541-50-6]; Down 200; 7uM; MCF7; HT_HG-U133A | 5.88e-05 | 190 | 159 | 8 | 4983_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A | 5.88e-05 | 190 | 159 | 8 | 2465_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 6.10e-05 | 191 | 159 | 8 | 4283_DN | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.33e-05 | 192 | 159 | 8 | 6752_DN | |
| Drug | clenbuterol | 6.41e-05 | 142 | 159 | 7 | CID000002783 | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 7.05e-05 | 195 | 159 | 8 | 1956_DN | |
| Drug | acetophenone | 7.07e-05 | 32 | 159 | 4 | CID000007410 | |
| Drug | Antigens, Polyomavirus Transforming | PMS1 ANK3 CENPF MTMR1 CEP128 JMJD1C SETDB2 SYNJ1 ADGRG2 CCDC82 UBAP2L POC5 CDC25C PCNA RAD17 | 7.22e-05 | 668 | 159 | 15 | ctd:D000952 |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 4689_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 2697_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 6745_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 6708_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 2052_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; PC3; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 2107_DN | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; HL60; HT_HG-U133A | 8.13e-05 | 199 | 159 | 8 | 2347_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 8.42e-05 | 200 | 159 | 8 | 2061_DN | |
| Disease | alpha fetoprotein measurement | 9.81e-07 | 100 | 154 | 7 | EFO_0010583 | |
| Disease | Syndactyly Cenani Lenz type | 2.71e-05 | 2 | 154 | 2 | C1859309 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.32e-04 | 364 | 154 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | response to erlotinib | 1.61e-04 | 4 | 154 | 2 | EFO_0007868 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 2.29e-04 | 23 | 154 | 3 | EFO_0004985, GO_1903493 | |
| Disease | Hepatoblastoma | 4.00e-04 | 6 | 154 | 2 | C0206624 | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | venous thromboembolism, fibrinogen measurement | 4.24e-04 | 67 | 154 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | Nonorganic psychosis | 4.74e-04 | 69 | 154 | 4 | C0349204 | |
| Disease | neuroimaging measurement | SECISBP2L MYH10 ANK3 RGPD1 APC REV3L JMJD1C SYNJ1 PRRC2C RAB3GAP2 SYCP1 MACF1 RERE WNK2 PLCE1 | 4.97e-04 | 1069 | 154 | 15 | EFO_0004346 |
| Disease | Antihypertensive use measurement | 5.04e-04 | 265 | 154 | 7 | EFO_0009927 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 5.59e-04 | 7 | 154 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | migraine disorder | 5.99e-04 | 357 | 154 | 8 | MONDO_0005277 | |
| Disease | cortical surface area measurement | MYH10 ANK3 MYCBP2 RGPD1 NPAS3 APC NPLOC4 KIAA0825 BCAP29 PRRC2C RAB3GAP2 MACF1 RERE SPAG17 CDC25C WNK2 PLCE1 | 6.84e-04 | 1345 | 154 | 17 | EFO_0010736 |
| Disease | vitamin D measurement, vitamin D dietary intake measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0004631, EFO_0008539 | |
| Disease | ascending aortic diameter | 8.59e-04 | 140 | 154 | 5 | EFO_0021787 | |
| Disease | endometrial cancer (is_implicated_in) | 8.77e-04 | 36 | 154 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | body fat percentage | 1.10e-03 | 488 | 154 | 9 | EFO_0007800 | |
| Disease | medulloblastoma (is_implicated_in) | 1.18e-03 | 10 | 154 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Childhood Medulloblastoma | 1.48e-03 | 43 | 154 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.48e-03 | 43 | 154 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.48e-03 | 43 | 154 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.48e-03 | 43 | 154 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.48e-03 | 43 | 154 | 3 | C0278876 | |
| Disease | Prostatic Neoplasms | 1.53e-03 | 616 | 154 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.53e-03 | 616 | 154 | 10 | C0376358 | |
| Disease | Mitral valve prolapse, response to surgery | 1.73e-03 | 12 | 154 | 2 | EFO_0009951, HP_0001634 | |
| Disease | response to antineoplastic agent | 1.83e-03 | 99 | 154 | 4 | GO_0097327 | |
| Disease | physical activity measurement | 1.86e-03 | 245 | 154 | 6 | EFO_0008002 | |
| Disease | Adenoid Cystic Carcinoma | 1.90e-03 | 100 | 154 | 4 | C0010606 | |
| Disease | Psychotic Disorders | 1.97e-03 | 101 | 154 | 4 | C0033975 | |
| Disease | Benign tumor of pancreas | 2.03e-03 | 13 | 154 | 2 | C0347284 | |
| Disease | response to fenofibrate | 2.28e-03 | 50 | 154 | 3 | GO_1901557 | |
| Disease | Medulloblastoma | 2.28e-03 | 50 | 154 | 3 | C0025149 | |
| Disease | gallstones | 2.51e-03 | 108 | 154 | 4 | EFO_0004210 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.72e-03 | 15 | 154 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | breast carcinoma | NRIP1 ATAD5 LMNB2 BCAS1 ADCY3 JMJD1C BABAM1 BRCA2 KMT5B DMD CCDC102B SPAG17 HSF2 | 2.73e-03 | 1019 | 154 | 13 | EFO_0000305 |
| Disease | neuroticism measurement, cognitive function measurement | 3.00e-03 | 566 | 154 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | nervousness | 3.10e-03 | 16 | 154 | 2 | NCIT_C74532 | |
| Disease | fourth ventricle volume measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0010303 | |
| Disease | Carcinoma, Granular Cell | 3.25e-03 | 116 | 154 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.25e-03 | 116 | 154 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.25e-03 | 116 | 154 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.25e-03 | 116 | 154 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.25e-03 | 116 | 154 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.25e-03 | 116 | 154 | 4 | C0001418 | |
| Disease | plasma beta-amyloid 1-40 measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0005659 | |
| Disease | puberty onset measurement | 4.24e-03 | 125 | 154 | 4 | EFO_0005677 | |
| Disease | Malignant neoplasm of breast | NRIP1 CENPF POU2F1 HMMR SLCO1B1 BRCA2 SYNJ2 ABRAXAS1 DDX18 WBP4 NHS MACF1 DMD | 4.25e-03 | 1074 | 154 | 13 | C0006142 |
| Disease | autoimmune thyroid disease | 4.36e-03 | 126 | 154 | 4 | EFO_0006812 | |
| Disease | Pancreatic carcinoma | 4.37e-03 | 19 | 154 | 2 | C0235974 | |
| Disease | diet measurement, HOMA-B | 4.37e-03 | 19 | 154 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | facial asymmetry measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0009751 | |
| Disease | optic disc size measurement | 4.52e-03 | 205 | 154 | 5 | EFO_0004832 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDKRSKADTGSSNQD | 366 | Q6UWZ7 | |
| DVQDNSQLKASTQKA | 616 | Q96QE3 | |
| KSTNATNSNVKDVGA | 1276 | Q96QE3 | |
| SLKKTESFQNAQAGS | 586 | Q92667 | |
| KQSETVDELTGKNNQ | 506 | Q6ZU80 | |
| EKSSNVKNENTSGTR | 1271 | Q9NR09 | |
| VKNENTSGTRKSENL | 1276 | Q9NR09 | |
| KASELKQEQETQGSS | 61 | P10092 | |
| KQEQETQGSSSAAQK | 66 | P10092 | |
| ENKTSDKANNNRGLS | 391 | O60239 | |
| AQKIKSGENAANIAS | 541 | O94910 | |
| LKQGQDNLSSVKETQ | 181 | P30040 | |
| KKQTVNQGVSSSSNS | 916 | Q8IZP9 | |
| SANQRTGSKKNVQAD | 801 | Q96L96 | |
| NGEAKESQSIGKQNS | 536 | A2A2Z9 | |
| LSNKGVLKTQAENTN | 131 | Q9UHQ4 | |
| IKDGQQSGTVSSQKQ | 586 | Q8N2N9 | |
| QDGSNAFISQKQNSK | 366 | O60563 | |
| ESLKNIKDSLQQSSG | 2036 | P11532 | |
| KQIKEQSENAQASGE | 1476 | Q96PN6 | |
| KTSVQGQVQKGNDES | 726 | Q9NSY1 | |
| KDNKLISANSSEGQD | 521 | Q9UBW5 | |
| VDASQSKAKQQDGAA | 341 | Q01814 | |
| SAQGNETKSNKCSQV | 1546 | Q149M9 | |
| DARQNSVADTNKTKG | 341 | Q13613 | |
| ALTAQNGKAAKNSEE | 551 | Q14978 | |
| SESQGNATKNDDLNK | 1276 | Q29RF7 | |
| AINSLQFSSSKGENN | 336 | O75943 | |
| KEAAAQQQESATTQK | 231 | P08100 | |
| KKQSNNDLFQVNSTS | 811 | Q9UPP5 | |
| NTSSSNGDTKLSQDK | 406 | Q96NI6 | |
| FSVEANSSNSQKNEK | 226 | Q96K31 | |
| TNSNAAGKQLRKESQ | 61 | Q8NC51 | |
| KGNTQTSKVSSLQAE | 906 | Q9H2M9 | |
| TNGSKDALNKFSDNT | 76 | Q9UM21 | |
| QNRNDAGIDSTNNKK | 371 | Q8NA72 | |
| EKKQSFSQGLSSTVQ | 91 | O15480 | |
| SSKQVSDTENNLNQG | 831 | Q8IV33 | |
| GKQKNSSDQEGNNIS | 271 | Q8IWI9 | |
| DKVTKNSSGIISENQ | 936 | Q8IWI9 | |
| SQGSDNLQEGQEKSK | 6 | Q6ZRS4 | |
| VQLKNNSDKDQSLGN | 486 | Q03252 | |
| QEKNNATSNRKSSVG | 386 | Q4FZB7 | |
| TKSEKNFQAVSQGSV | 1366 | Q15652 | |
| GTNKEATSTGKLNQE | 186 | Q96A33 | |
| EAFGNAKTVKNDNSS | 246 | Q7Z406 | |
| GNGNIKLSQTSNVDK | 176 | P12004 | |
| NKISGSAFSKTDENN | 386 | Q9Y233 | |
| ETKNQVNGTRANKSD | 571 | Q14123 | |
| NSKAEKSSGEQQQNG | 591 | Q14123 | |
| TDTAKNSNNEKFIGD | 321 | Q2TBE0 | |
| NKTGEITASSNKSLN | 51 | Q8TAT6 | |
| KTELNLSKGSLTNDQ | 586 | Q5W0B1 | |
| EQIDQGSKLNQTSKS | 46 | O94854 | |
| DGGKDQNSLSSEQQK | 161 | Q6P1A2 | |
| NKTNAVEENKAFSSQ | 676 | P48552 | |
| LKQKAAQQAASSSGQ | 301 | Q8N752 | |
| NNKFKTTVVNDNGLS | 1096 | P16885 | |
| AAVQQKNSLQSESGN | 86 | Q96RD7 | |
| KFQGASNLTLSETQN | 26 | Q9NVP1 | |
| QSADSKTKENVNATE | 956 | O00410 | |
| ANKKDAETGSSQCQT | 831 | A7KAX9 | |
| NSKNSNGQELEKTLE | 1691 | Q7Z6Z7 | |
| SKNKSEQDAQGASQD | 2271 | Q7Z6Z7 | |
| VLSQLTTDNKGNSKA | 236 | O94916 | |
| QTQKAGEGKRNQTTE | 191 | Q9UBG3 | |
| SLVDFSTNNQKKAQD | 421 | Q9BQG0 | |
| SSSANKENDNGNLVD | 146 | P30307 | |
| EQGNFKSLSQSSKEA | 1436 | Q7Z6E9 | |
| QSLNVQSKSNEESGD | 66 | P14859 | |
| TNELLKSKFSENGNQ | 146 | O75330 | |
| GKQGKEQNQDSQTEA | 486 | Q8N573 | |
| LKATAEQISSQTGNK | 96 | Q16698 | |
| DEENKNQQGEKLTTS | 306 | Q8N4S0 | |
| QSNTFDVQNKNSDLG | 2821 | Q3L8U1 | |
| DVQNKNSDLGSSKSV | 2826 | Q3L8U1 | |
| SFSGEKANTKTQRSQ | 1586 | Q9Y2F5 | |
| ESFNGSKTNALNVSQ | 111 | Q9NWV8 | |
| KESNSSSNQLDKSQK | 381 | A2AJT9 | |
| GNTSNKEQLTATKTE | 1401 | P51587 | |
| DNQNNSKSEAGGLKQ | 1116 | P49454 | |
| ETNQKLVADSKASQQ | 96 | Q01850 | |
| AQTKLSNQGDQKGST | 341 | Q9UKT4 | |
| QSFSTKDQDNDLNTG | 241 | Q15485 | |
| QGISFSSNNEVKSKI | 1691 | O75417 | |
| LLTGEEQNKSQQNSS | 91 | O60519 | |
| VNTNGFASSNKEDKS | 991 | O60266 | |
| AEKASNQKELESNGS | 3351 | Q12955 | |
| KQSEAENTEQVNKNS | 356 | Q9NRY5 | |
| ANSGSATKNTNVKSL | 636 | Q9Y4F3 | |
| NQDSKQGEQETKNRS | 351 | Q5SQI0 | |
| KEEQKSNTAGSQSQV | 441 | Q02790 | |
| LKSDKANFTSQETQG | 321 | O75363 | |
| RQFSTKEDTNNKEQG | 191 | Q68D86 | |
| ELSGNIKEESKSQNS | 326 | Q68D86 | |
| SNIDKNTKNAFQDIS | 426 | P54277 | |
| ESFGNAKTVKNDNSS | 226 | P35580 | |
| NESVQSVDKLGKQTS | 356 | A6NGG8 | |
| QKLSSTTKSADQLNG | 1641 | P0DJD0 | |
| SENKGLETTKNNVVQ | 411 | Q03933 | |
| GKSQQASNKTNSTEV | 446 | Q2WGJ9 | |
| SEQTKGKASSQANNV | 111 | Q96M34 | |
| ALSAKQNGSSSAVQK | 276 | Q9HCJ0 | |
| NAGNIVSASTTNQKL | 596 | O43426 | |
| LSAGNIVNASTTNKK | 591 | O15056 | |
| KNTGNQKALDSDAES | 186 | Q7Z3H4 | |
| NDVSEKLAQSKETNG | 121 | Q8N3X1 | |
| KLAQSKETNGNQSTD | 126 | Q8N3X1 | |
| KSASDNSKAEETQGN | 1386 | Q6T4R5 | |
| NGLKNSEKESTVNSI | 756 | Q9P212 | |
| QKEKQNESTNGNSEV | 836 | Q9HCM1 | |
| LKQKAAQQAASSSGQ | 301 | P48729 | |
| QFLKVSNVSANNKSD | 556 | Q6ZW05 | |
| KKQATGIQQAQSSAS | 1731 | Q9Y520 | |
| TQKSKASQGSDLEQN | 361 | Q96T21 | |
| NGNAKDENIQQKLSS | 401 | Q93073 | |
| QFKSSKKSNNGTDVN | 1361 | O75592 | |
| SATIAINAKNANEKN | 411 | Q8IXF0 | |
| NDNNSATAEESTKKN | 61 | Q9P2R6 | |
| FQQGTTKLSVENNKT | 146 | Q16585 | |
| TNDEKDQTANLTNQG | 301 | Q9Y6L6 | |
| SADKKDFTAQNQTEN | 1981 | Q6Q759 | |
| SSGINSTKSQDKDVN | 56 | Q9Y5Q9 | |
| NSSKIDTNKSIAQGI | 1011 | Q8NFU7 | |
| KANEKTESSSAQQVA | 756 | P25440 | |
| ENSSQENENKTKVSG | 426 | Q14865 | |
| QNLTKQTGLSKNASS | 2376 | P25054 | |
| HVNSISGTKQSKENQ | 2591 | P25054 | |
| DSKDNQAKQNVGNGS | 2696 | P25054 | |
| DSQSSQDELQSKQSK | 451 | Q9UPV0 | |
| KNSNQLGGNTESSES | 486 | Q9H9A5 | |
| EAFGNAKTVKNDNSS | 226 | P35749 | |
| ASNSQNSQAKIITGK | 2226 | A4UGR9 | |
| KGKNVQATLNVESDQ | 46 | O96001 | |
| QTKFQNGKSKTSENS | 6 | Q96PP4 | |
| NTGNDLKENVKSDSV | 1366 | A0JNW5 | |
| KAENQNESSQGKSIG | 126 | Q9UKI8 | |
| TSIKGASQKEVNAQS | 66 | Q96T68 | |
| KESGQNAQTGANSKL | 146 | Q86UP3 | |
| ENKLKQGISQDLASS | 21 | A6PVC2 | |
| ELATASSGENSKNQK | 1061 | P61129 | |
| GNSGSNSNKAVKEND | 1256 | Q8NI27 | |
| QKDLTQAKNGFSSVQ | 611 | Q14157 | |
| GLQKNAKVTNSDNED | 101 | Q8NB66 | |
| QTNKNTEKGLDNSVT | 601 | O60673 | |
| KSSETGSTKDNFIQN | 846 | O60673 | |
| KIKNGQAASDNVFST | 586 | Q9NXZ1 | |
| VNNKSDCKIQNSTGS | 1326 | Q9Y5Y9 | |
| AKTNLSKNGENIDSD | 51 | Q15431 | |
| NSDKGNRNNSQLEKT | 456 | Q9BX26 | |
| GSQTGKKQQSTALQA | 476 | Q92610 | |
| SIQKQNSLGSNEEKS | 271 | O75554 | |
| EDTQLINFTKKNGST | 196 | O75830 | |
| KDQGLQKTTNSSLEE | 726 | Q709C8 | |
| GNSEQTKDENSSKST | 1136 | P49790 | |
| QAGDDSNSNKKNADL | 221 | P01833 | |
| GQKTNQEILKNVESS | 1171 | Q86X10 | |
| ESGAKNKSTEQQQAA | 266 | P49750 | |
| SSKNEELQGNDSKIT | 86 | Q9UBW7 | |
| NTVQYGTSDNKKDNT | 66 | Q96AP4 | |
| GASKNSQLGQSKDQD | 111 | Q08ER8 | |
| NDNSKADGQVVSSEK | 521 | Q13342 | |
| AQVNNSNNKKGTFTD | 2146 | Q9Y3S1 | |
| ENSLEGKNKDNSSNE | 666 | Q9HBM0 | |
| QSERQSQDSSSGKKV | 196 | Q6XPR3 | |
| ETKGDSVEKNQGTQQ | 416 | Q6PJT7 | |
| SADKSDQNNTAEGKN | 291 | Q9NXG2 | |
| VEANSSNSQKNEKAL | 196 | Q96EF9 | |
| GETFSQDSNLNLNKK | 81 | Q9BS34 | |
| QDSNLNLNKKVSTGV | 86 | Q9BS34 | |
| TKSTGTSNQQAQGKD | 176 | Q5TIE3 | |
| AKETNNSFQELATKN | 111 | P23276 | |
| KSINSANKFTGKNQE | 661 | O75096 | |
| FESSTNNNKDTKQKA | 621 | Q9UM54 |